HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:52.79,NPI:4.036,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:47.03333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-0362,GRADE:2,COHORT:1,PATIENT_ID:MB-0362,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:32.61,NPI:6.032,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:20.43333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-0346,GRADE:3,COHORT:1,PATIENT_ID:MB-0346,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:66.83,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:138.1333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0386,GRADE:3,COHORT:1,PATIENT_ID:MB-0386,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:71.21,NPI:5.042,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:119.8,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-0574,GRADE:3,COHORT:1,PATIENT_ID:MB-0574,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:60.77,NPI:3.046,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:101.2333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0503,GRADE:2,COHORT:1,PATIENT_ID:MB-0503,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:56.34,NPI:4.028,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:14,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:102.5666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0641,GRADE:2,COHORT:1,PATIENT_ID:MB-0641,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:49.5,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:125.7,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-0201,GRADE:3,COHORT:1,PATIENT_ID:MB-0201,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:43.39,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:131.0666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:1,name:MB-0218,GRADE:3,COHORT:1,PATIENT_ID:MB-0218,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:50.82,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:182.9,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0316,GRADE:3,COHORT:1,PATIENT_ID:MB-0316,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:57.79,NPI:6.096,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:48,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:9.066666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-0189,GRADE:3,COHORT:1,PATIENT_ID:MB-0189,TUMOR_STAGE:4
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:83.68,NPI:3.074,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:37,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:149.4,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0891,GRADE:1,COHORT:1,PATIENT_ID:MB-0891,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:60.89,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:97.26666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0658,GRADE:3,COHORT:1,PATIENT_ID:MB-0658,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:50.62,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:175.8,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0899,GRADE:2,COHORT:1,PATIENT_ID:MB-0899,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:58.08,NPI:3.036,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:114.6,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0605,GRADE:2,COHORT:1,PATIENT_ID:MB-0605,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:62.7,NPI:4.022,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:11,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:86.13333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0258,GRADE:3,COHORT:1,PATIENT_ID:MB-0258,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:60.74,NPI:5.042,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:neg,OS_MONTHS:45.8,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0506,GRADE:3,COHORT:1,PATIENT_ID:MB-0506,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:34.92,NPI:4.032,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:76.73333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-0420,GRADE:3,COHORT:1,PATIENT_ID:MB-0420,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:50.45,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:81.33333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0223,GRADE:3,COHORT:1,PATIENT_ID:MB-0223,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:40.07,NPI:4.046,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:132.5333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:7,name:MB-0445,GRADE:2,COHORT:1,PATIENT_ID:MB-0445,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:57.56,NPI:5.038,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:19,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:144.4,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0199,GRADE:3,COHORT:1,PATIENT_ID:MB-0199,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:47.92,NPI:3.034,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:61.9,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:9,name:MB-0517,GRADE:2,COHORT:1,PATIENT_ID:MB-0517,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:62.72,NPI:2.018,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:9,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:59.8,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0155,GRADE:1,COHORT:1,PATIENT_ID:MB-0155,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:85.21,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:55.93333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0428,GRADE:3,COHORT:1,PATIENT_ID:MB-0428,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:60.07,NPI:4.046,CELLULARITY:moderate,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-0117,GRADE:2,COHORT:1,PATIENT_ID:MB-0117,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:70.6,NPI:4.056,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:28,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:63.86666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-0906,GRADE:3,COHORT:1,PATIENT_ID:MB-0906,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:53.45,NPI:4.022,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:11,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:188.3333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0249,GRADE:3,COHORT:1,PATIENT_ID:MB-0249,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:52.43,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:160,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:18.93333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-MED,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0660,GRADE:3,COHORT:1,PATIENT_ID:MB-0660,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:57.27,NPI:3.058,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:29,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:73.7,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0497,GRADE:2,COHORT:1,PATIENT_ID:MB-0497,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:69.79,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:45.5,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-0434,GRADE:3,COHORT:1,PATIENT_ID:MB-0434,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:85.39,NPI:5.044,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:54.33333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0143,GRADE:3,COHORT:1,PATIENT_ID:MB-0143,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:73.39,NPI:4.064,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:32,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:117.0333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0513,GRADE:2,COHORT:1,PATIENT_ID:MB-0513,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:38.86,NPI:4.038,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:19,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:174.2666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:9,name:MB-0541,GRADE:3,COHORT:1,PATIENT_ID:MB-0541,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.95,NPI:5.056,CELLULARITY:moderate,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:28,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0653,GRADE:3,COHORT:1,PATIENT_ID:MB-0653,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:56.84,NPI:3.036,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:99.33333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0455,GRADE:2,COHORT:1,PATIENT_ID:MB-0455,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:66.11,NPI:2.024,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:12,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:194.5333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0540,GRADE:1,COHORT:1,PATIENT_ID:MB-0540,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:74.58,NPI:6.086,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:43,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:61.1,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0384,GRADE:3,COHORT:1,PATIENT_ID:MB-0384,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:75.71,NPI:4.062,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:31,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:80.66666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0637,GRADE:3,COHORT:1,PATIENT_ID:MB-0637,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:71.5,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:114.7666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-0157,GRADE:3,COHORT:1,PATIENT_ID:MB-0157,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.67,NPI:3.052,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:45.03333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0443,GRADE:2,COHORT:1,PATIENT_ID:MB-0443,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:41.31,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:118.2,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:7,name:MB-0584,GRADE:3,COHORT:1,PATIENT_ID:MB-0584,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:80.34,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:55,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:49.43333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0292,GRADE:3,COHORT:1,PATIENT_ID:MB-0292,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:86.28,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:50.53333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0322,GRADE:2,COHORT:1,PATIENT_ID:MB-0322,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:48.93,NPI:4.042,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:71.5,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-0501,GRADE:3,COHORT:1,PATIENT_ID:MB-0501,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:48.58,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:26.26666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-0401,GRADE:3,COHORT:1,PATIENT_ID:MB-0401,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:74.07,NPI:4.054,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:27,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:147.9333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0140,GRADE:2,COHORT:1,PATIENT_ID:MB-0140,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:83.19,NPI:3.036,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:27.46666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-MUC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0606,GRADE:2,COHORT:1,PATIENT_ID:MB-0606,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.31,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:24.33333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0666,GRADE:3,COHORT:1,PATIENT_ID:MB-0666,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:77.48,NPI:5.048,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:24,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:89.36666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0598,GRADE:2,COHORT:1,PATIENT_ID:MB-0598,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:61.11,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:100,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:43.13333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-0453,GRADE:3,COHORT:1,PATIENT_ID:MB-0453,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:51.33,NPI:3.036,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:150.5666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0138,GRADE:2,COHORT:1,PATIENT_ID:MB-0138,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:70.53,NPI:4.058,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:29,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:92.76666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0579,GRADE:2,COHORT:1,PATIENT_ID:MB-0579,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:76.49,NPI:3.034,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:107.4666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-0471,GRADE:2,COHORT:1,PATIENT_ID:MB-0471,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:38.9,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:94.23333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-MUC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-0619,GRADE:3,COHORT:1,PATIENT_ID:MB-0619,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:64.57,NPI:4.054,CELLULARITY:moderate,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:27,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:5.433333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0171,GRADE:3,COHORT:1,PATIENT_ID:MB-0171,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:67.38,NPI:4.032,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:185.1666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0310,GRADE:2,COHORT:1,PATIENT_ID:MB-0310,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:70.04,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:33.56666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0621,GRADE:2,COHORT:1,PATIENT_ID:MB-0621,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:48.99,NPI:5.038,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:19,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:119.3333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:6,name:MB-0614,GRADE:3,COHORT:1,PATIENT_ID:MB-0614,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:39.86,NPI:4.036,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:62.76666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-0372,GRADE:3,COHORT:1,PATIENT_ID:MB-0372,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:34.68,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:1.433333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:1,name:MB-0374,GRADE:3,COHORT:1,PATIENT_ID:MB-0374,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:59.05,NPI:4.044,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:136.4666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0382,GRADE:2,COHORT:1,PATIENT_ID:MB-0382,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.49,NPI:4.032,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:157.4333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0066,GRADE:2,COHORT:1,PATIENT_ID:MB-0066,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:79.73,NPI:6.052,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:152.0666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0144,GRADE:3,COHORT:1,PATIENT_ID:MB-0144,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:77.48,NPI:3.032,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:100.4666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0596,GRADE:2,COHORT:1,PATIENT_ID:MB-0596,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:37.87,NPI:4.032,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:10.83333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-0164,GRADE:3,COHORT:1,PATIENT_ID:MB-0164,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:75.63,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:122.2,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0215,GRADE:2,COHORT:1,PATIENT_ID:MB-0215,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:81.0,NPI:5.044,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:86.0,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-0146,GRADE:3,COHORT:1,PATIENT_ID:MB-0146,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:45.5,NPI:3.038,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:19,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:71.5,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:7,name:MB-0229,GRADE:2,COHORT:1,PATIENT_ID:MB-0229,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:56.38,NPI:3.024,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:12,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:60.7,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0505,GRADE:1,COHORT:1,PATIENT_ID:MB-0505,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:51.38,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:140.7666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0102,GRADE:2,COHORT:1,PATIENT_ID:MB-0102,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:74.96,NPI:6.046,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:59.5,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0569,GRADE:3,COHORT:1,PATIENT_ID:MB-0569,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:62.81,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:114.4666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0516,GRADE:3,COHORT:1,PATIENT_ID:MB-0516,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:55.36,NPI:6.056,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:28,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:122.0,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0272,GRADE:3,COHORT:1,PATIENT_ID:MB-0272,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:76.72,NPI:5.056,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:28,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:106.9666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-0585,GRADE:3,COHORT:1,PATIENT_ID:MB-0585,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:77.22,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:36.63333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-0494,GRADE:3,COHORT:1,PATIENT_ID:MB-0494,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:82.53,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:42.96666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0306,GRADE:3,COHORT:1,PATIENT_ID:MB-0306,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:60.48,NPI:3.042,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:61.96666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0463,GRADE:2,COHORT:1,PATIENT_ID:MB-0463,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:43.37,NPI:6.036,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:144.7666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-0198,GRADE:3,COHORT:1,PATIENT_ID:MB-0198,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:86.24,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:58.76666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0203,GRADE:3,COHORT:1,PATIENT_ID:MB-0203,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:53.1,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:87.83333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:null,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0607,GRADE:3,COHORT:1,PATIENT_ID:MB-0607,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:84.41,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:47.43333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0631,GRADE:2,COHORT:1,PATIENT_ID:MB-0631,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:73.24,NPI:5.134,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:67,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:89.9,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:OTHER,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-0363,GRADE:2,COHORT:1,PATIENT_ID:MB-0363,TUMOR_STAGE:4
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:81.89,NPI:5.042,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:116.1,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0427,GRADE:2,COHORT:1,PATIENT_ID:MB-0427,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:61.99,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:65,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:110.9666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0519,GRADE:3,COHORT:1,PATIENT_ID:MB-0519,TUMOR_STAGE:3
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:78.41,NPI:6.044,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:131.1333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-0371,GRADE:3,COHORT:1,PATIENT_ID:MB-0371,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:83.9,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:69.33333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0380,GRADE:3,COHORT:1,PATIENT_ID:MB-0380,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:77.72,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-0221,GRADE:3,COHORT:1,PATIENT_ID:MB-0221,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:81.88,NPI:2.044,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:122.7,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0348,GRADE:1,COHORT:1,PATIENT_ID:MB-0348,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.93,NPI:4.052,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:90.23333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0261,GRADE:1,COHORT:1,PATIENT_ID:MB-0261,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:68.47,NPI:6.042,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:31.0,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-0576,GRADE:3,COHORT:1,PATIENT_ID:MB-0576,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:66.58,NPI:6.062,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:31,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:36.43333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-MUC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0385,GRADE:3,COHORT:1,PATIENT_ID:MB-0385,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:82.87,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:45,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:23.33333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:OTHER,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-0659,GRADE:2,COHORT:1,PATIENT_ID:MB-0659,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:29.98,NPI:4.028,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:14,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:337.0333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-0270,GRADE:3,COHORT:1,PATIENT_ID:MB-0270,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:48.22,NPI:4.058,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:29,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:135.6666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:7,name:MB-0379,GRADE:2,COHORT:1,PATIENT_ID:MB-0379,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:73.22,NPI:4.038,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:19,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:109.8333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0527,GRADE:2,COHORT:1,PATIENT_ID:MB-0527,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:64.28,NPI:4.032,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:64.03333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0624,GRADE:2,COHORT:1,PATIENT_ID:MB-0624,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:68.66,CELLULARITY:moderate,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:186.5333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0273,GRADE:2,COHORT:1,PATIENT_ID:MB-0273,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:44.64,NPI:4.066,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:33,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:75.33333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-0050,GRADE:2,COHORT:1,PATIENT_ID:MB-0050,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:81.44,NPI:3.044,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:114.0,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0460,GRADE:2,COHORT:1,PATIENT_ID:MB-0460,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:82.5,NPI:2.048,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:24,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:69.4,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0654,GRADE:1,COHORT:1,PATIENT_ID:MB-0654,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:90.02,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:46.83333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-MUC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0454,GRADE:2,COHORT:1,PATIENT_ID:MB-0454,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:56.28,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:38.13333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-0392,GRADE:3,COHORT:1,PATIENT_ID:MB-0392,TUMOR_STAGE:4
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:74.76,NPI:5.044,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:170.3,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0336,GRADE:3,COHORT:1,PATIENT_ID:MB-0336,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:58.35,NPI:4.026,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:13,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:105.6,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-0467,GRADE:3,COHORT:1,PATIENT_ID:MB-0467,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:72.26,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:146.0333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0349,GRADE:3,COHORT:1,PATIENT_ID:MB-0349,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:57.15,NPI:5.056,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:28,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:97.3,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-0378,GRADE:3,COHORT:1,PATIENT_ID:MB-0378,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:38.78,NPI:6.072,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:36,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:113.4333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:1,name:MB-0176,GRADE:3,COHORT:1,PATIENT_ID:MB-0176,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:78.86,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:74.46666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-0429,GRADE:3,COHORT:1,PATIENT_ID:MB-0429,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:58.56,NPI:2.022,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:11,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:57.23333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0397,GRADE:1,COHORT:1,PATIENT_ID:MB-0397,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.79,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:149.8666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0571,GRADE:1,COHORT:1,PATIENT_ID:MB-0571,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:50.48,NPI:4.084,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:42,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:131.1,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0426,GRADE:2,COHORT:1,PATIENT_ID:MB-0426,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:74.09,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:116.6333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-0135,GRADE:3,COHORT:1,PATIENT_ID:MB-0135,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:83.89,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:150,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:39.16666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0112,GRADE:3,COHORT:1,PATIENT_ID:MB-0112,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.32,NPI:4.026,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:13,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:55.2,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0352,GRADE:3,COHORT:1,PATIENT_ID:MB-0352,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:71.06,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:93.3,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0644,GRADE:2,COHORT:1,PATIENT_ID:MB-0644,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:32.99,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:29.66666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-0601,GRADE:3,COHORT:1,PATIENT_ID:MB-0601,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.28,NPI:4.034,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:181.4666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0568,GRADE:2,COHORT:1,PATIENT_ID:MB-0568,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.62,NPI:5.068,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:34,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:125.6,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0328,GRADE:3,COHORT:1,PATIENT_ID:MB-0328,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:79.34,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:45,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:177.5333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0325,GRADE:3,COHORT:1,PATIENT_ID:MB-0325,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:57.87,NPI:5.052,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:32.86666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0358,GRADE:3,COHORT:1,PATIENT_ID:MB-0358,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:56.58,NPI:6.094,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:47,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:140.0666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-0413,GRADE:3,COHORT:1,PATIENT_ID:MB-0413,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:26.36,NPI:4.024,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:12,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:32.63333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:6,name:MB-0636,GRADE:3,COHORT:1,PATIENT_ID:MB-0636,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:62.4,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:147.6666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0145,GRADE:2,COHORT:1,PATIENT_ID:MB-0145,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:75.18,NPI:6.056,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:28,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:146.0,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-0195,GRADE:3,COHORT:1,PATIENT_ID:MB-0195,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:66.72,NPI:5.032,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:33.8,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0422,GRADE:2,COHORT:1,PATIENT_ID:MB-0422,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:49.61,NPI:5.042,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:74.46666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:1,name:MB-0483,GRADE:3,COHORT:1,PATIENT_ID:MB-0483,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:76.68,NPI:4.078,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:39,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:151.6666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0317,GRADE:3,COHORT:1,PATIENT_ID:MB-0317,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:57.57,NPI:4.064,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:32,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:89.96666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0486,GRADE:3,COHORT:1,PATIENT_ID:MB-0486,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:47.62,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:109.2,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-0139,GRADE:2,COHORT:1,PATIENT_ID:MB-0139,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:57.61,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:91.73333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0257,GRADE:2,COHORT:1,PATIENT_ID:MB-0257,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:37.3,NPI:4.056,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:28,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:72.66666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-0345,GRADE:2,COHORT:1,PATIENT_ID:MB-0345,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:72.69,NPI:5.046,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:neg,OS_MONTHS:143.1666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0375,GRADE:3,COHORT:1,PATIENT_ID:MB-0375,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:77.92,NPI:4.042,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:104.3,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0419,GRADE:2,COHORT:1,PATIENT_ID:MB-0419,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:51.86,NPI:4.026,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:13,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:94.56666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0480,GRADE:3,COHORT:1,PATIENT_ID:MB-0480,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:77.94,NPI:2.094,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:47,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:151.1666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0311,GRADE:1,COHORT:1,PATIENT_ID:MB-0311,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:47.64,NPI:6.064,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:32,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:144.9666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:null,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:6,name:MB-0324,GRADE:3,COHORT:1,PATIENT_ID:MB-0324,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:74.79,NPI:6.062,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:31,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:61.9,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-0368,GRADE:3,COHORT:1,PATIENT_ID:MB-0368,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:46.87,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:96.96666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:2,name:MB-0389,GRADE:3,COHORT:1,PATIENT_ID:MB-0389,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:45.76,NPI:4.042,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:71.0,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-0248,GRADE:3,COHORT:1,PATIENT_ID:MB-0248,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:84.22,NPI:3.056,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:28,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:36.26666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0035,GRADE:2,COHORT:1,PATIENT_ID:MB-0035,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:83.01,NPI:4.044,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:144.7,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0904,GRADE:2,COHORT:1,PATIENT_ID:MB-0904,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:82.73,NPI:4.046,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:95.86666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0119,GRADE:2,COHORT:1,PATIENT_ID:MB-0119,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:79.48,NPI:4.042,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:25.53333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-0650,GRADE:2,COHORT:1,PATIENT_ID:MB-0650,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:79.38,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0204,GRADE:1,COHORT:1,PATIENT_ID:MB-0204,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:68.41,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:109.0333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-MUC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0184,GRADE:2,COHORT:1,PATIENT_ID:MB-0184,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:70.5,NPI:6.054,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:27,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:111.0,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:OTHER,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-0600,GRADE:3,COHORT:1,PATIENT_ID:MB-0600,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:55.28,NPI:4.032,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:22.46666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0400,GRADE:3,COHORT:1,PATIENT_ID:MB-0400,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:59.84,NPI:3.062,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:31,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:61.7,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0511,GRADE:2,COHORT:1,PATIENT_ID:MB-0511,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:36.56,NPI:4.044,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:67.46666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-0500,GRADE:3,COHORT:1,PATIENT_ID:MB-0500,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:70.22,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:111.2,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:OTHER,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0150,GRADE:2,COHORT:1,PATIENT_ID:MB-0150,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:79.61,NPI:5.038,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:19,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:43.1,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-0895,GRADE:3,COHORT:1,PATIENT_ID:MB-0895,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:51.74,NPI:3.044,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:64.23333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0366,GRADE:2,COHORT:1,PATIENT_ID:MB-0366,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:83.99,NPI:6.088,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:44,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:3.766666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0173,GRADE:3,COHORT:1,PATIENT_ID:MB-0173,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.16,NPI:4.078,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:39,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:66.63333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0131,GRADE:3,COHORT:1,PATIENT_ID:MB-0131,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:55.02,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:141.1666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-MED,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0206,GRADE:3,COHORT:1,PATIENT_ID:MB-0206,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:56.32,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:186.2,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-0315,GRADE:2,COHORT:1,PATIENT_ID:MB-0315,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:40.5,NPI:6.048,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:24,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:15.06666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-0361,GRADE:3,COHORT:1,PATIENT_ID:MB-0361,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:83.92,NPI:6.052,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:41.16666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:null,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-0545,GRADE:3,COHORT:1,PATIENT_ID:MB-0545,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:64.01,NPI:6.094,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:47,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:93.5,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0370,GRADE:3,COHORT:1,PATIENT_ID:MB-0370,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:79.12,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:84.2,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0642,GRADE:1,COHORT:1,PATIENT_ID:MB-0642,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.61,NPI:4.114,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:57,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:85.13333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0431,GRADE:2,COHORT:1,PATIENT_ID:MB-0431,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:68.45,NPI:4.042,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:85.96666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0181,GRADE:2,COHORT:1,PATIENT_ID:MB-0181,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:79.52,NPI:4.042,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:121.9666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0603,GRADE:2,COHORT:1,PATIENT_ID:MB-0603,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:47.13,NPI:3.018,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:9,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:164.5,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-0295,GRADE:1,COHORT:1,PATIENT_ID:MB-0295,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.86,NPI:3.034,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:101.9,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0618,GRADE:2,COHORT:1,PATIENT_ID:MB-0618,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:60.0,NPI:4.052,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:130.9,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0496,GRADE:1,COHORT:1,PATIENT_ID:MB-0496,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:54.6,NPI:4.036,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:139.1666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-0411,GRADE:2,COHORT:1,PATIENT_ID:MB-0411,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:48.07,NPI:5.056,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:NO,LATERALITY:null,TUMOR_SIZE:28,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:3.366666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:null,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-0285,GRADE:2,COHORT:1,PATIENT_ID:MB-0285,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:83.58,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:132.5666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0360,GRADE:1,COHORT:1,PATIENT_ID:MB-0360,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:44.21,NPI:3.044,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:null,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:null,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-0359,GRADE:2,COHORT:1,PATIENT_ID:MB-0359,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:59.75,NPI:4.058,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:29,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:152.9333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0344,GRADE:2,COHORT:1,PATIENT_ID:MB-0344,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:75.67,NPI:3.044,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:62.63333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0583,GRADE:2,COHORT:1,PATIENT_ID:MB-0583,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:46.0,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:128.3666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-0202,GRADE:3,COHORT:1,PATIENT_ID:MB-0202,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:60.78,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:36.76666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0485,GRADE:3,COHORT:1,PATIENT_ID:MB-0485,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:51.15,NPI:4.028,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:14,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:98.7,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0609,GRADE:2,COHORT:1,PATIENT_ID:MB-0609,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.89,NPI:6.074,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:37,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0538,GRADE:3,COHORT:1,PATIENT_ID:MB-0538,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:50.48,NPI:5.048,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:24,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:70.73333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0197,GRADE:3,COHORT:1,PATIENT_ID:MB-0197,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:57.41,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:63.0,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0410,GRADE:2,COHORT:1,PATIENT_ID:MB-0410,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:53.64,NPI:5.052,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:193.9666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-0528,GRADE:3,COHORT:1,PATIENT_ID:MB-0528,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:53.75,NPI:6.104,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:52,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:47.63333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-0165,GRADE:3,COHORT:1,PATIENT_ID:MB-0165,TUMOR_STAGE:3
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:63.77,NPI:4.024,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:12,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:63.03333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-0152,GRADE:3,COHORT:1,PATIENT_ID:MB-0152,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:53.16,NPI:4.038,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:19,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:1.766666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-0148,GRADE:3,COHORT:1,PATIENT_ID:MB-0148,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:77.96,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:45,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:44.23333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0594,GRADE:3,COHORT:1,PATIENT_ID:MB-0594,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:52.2,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:212.2,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0521,GRADE:2,COHORT:1,PATIENT_ID:MB-0521,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:59.07,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:neg,OS_MONTHS:143.1333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0532,GRADE:3,COHORT:1,PATIENT_ID:MB-0532,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:67.88,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:147.3666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-0536,GRADE:3,COHORT:1,PATIENT_ID:MB-0536,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:92.14,NPI:5.064,CELLULARITY:moderate,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:32,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:40.7,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-0319,GRADE:2,COHORT:1,PATIENT_ID:MB-0319,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:43.4,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:125.8,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-0491,GRADE:2,COHORT:1,PATIENT_ID:MB-0491,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:60.71,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:63.5,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0404,GRADE:3,COHORT:1,PATIENT_ID:MB-0404,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:53.72,NPI:4.044,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:149.7666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0243,GRADE:2,COHORT:1,PATIENT_ID:MB-0243,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:33.8,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:79.36666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-0580,GRADE:3,COHORT:1,PATIENT_ID:MB-0580,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:70.49,NPI:3.066,CELLULARITY:moderate,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:33,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:169.0,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-0312,GRADE:2,COHORT:1,PATIENT_ID:MB-0312,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:45.43,NPI:4.046,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:140.8666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-0060,GRADE:3,COHORT:1,PATIENT_ID:MB-0060,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:60.62,NPI:4.016,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:8,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:61.43333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0649,GRADE:1,COHORT:1,PATIENT_ID:MB-0649,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:73.46,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:60,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:19.73333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-0643,GRADE:3,COHORT:1,PATIENT_ID:MB-0643,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:96.29,NPI:6.052,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:7.866666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0581,GRADE:3,COHORT:1,PATIENT_ID:MB-0581,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:65.02,NPI:4.038,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:19,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:85.73333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-0383,GRADE:3,COHORT:1,PATIENT_ID:MB-0383,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:57.99,NPI:3.032,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-MUC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-0142,GRADE:2,COHORT:1,PATIENT_ID:MB-0142,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:50.98,NPI:2.034,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:63.73333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0320,GRADE:1,COHORT:1,PATIENT_ID:MB-0320,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:48.13,NPI:4.056,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:28,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:173.6333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-0207,GRADE:2,COHORT:1,PATIENT_ID:MB-0207,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:76.4,NPI:5.076,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:38,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:43.1,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0167,GRADE:3,COHORT:1,PATIENT_ID:MB-0167,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:84.0,NPI:4.034,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:117.7666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0591,GRADE:3,COHORT:1,PATIENT_ID:MB-0591,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:60.2,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:60,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:48.8,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-MED,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-0613,GRADE:2,COHORT:1,PATIENT_ID:MB-0613,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:55.52,NPI:5.046,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:184.7666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0313,GRADE:3,COHORT:1,PATIENT_ID:MB-0313,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:46.85,NPI:4.048,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:24,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:123.2666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-0599,GRADE:2,COHORT:1,PATIENT_ID:MB-0599,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:62.92,NPI:4.046,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:null,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:192.6,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0286,GRADE:3,COHORT:1,PATIENT_ID:MB-0286,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:48.1,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:55,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:128.5666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-0575,GRADE:2,COHORT:1,PATIENT_ID:MB-0575,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:41.41,NPI:4.054,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:27,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:146.9,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-0214,GRADE:3,COHORT:1,PATIENT_ID:MB-0214,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:59.96,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:125.8,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-0589,GRADE:2,COHORT:1,PATIENT_ID:MB-0589,TUMOR_STAGE:4
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.32,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:180,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:96.9,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-0406,GRADE:3,COHORT:1,PATIENT_ID:MB-0406,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:54.43,NPI:4.046,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:62.8,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0452,GRADE:3,COHORT:1,PATIENT_ID:MB-0452,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:40.65,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:80.83333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-0524,GRADE:3,COHORT:1,PATIENT_ID:MB-0524,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:73.64,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:1.233333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0880,GRADE:1,COHORT:1,PATIENT_ID:MB-0880,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:76.22,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:null,TUMOR_SIZE:65,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:163.2,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:OTHER,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0573,GRADE:2,COHORT:1,PATIENT_ID:MB-0573,TUMOR_STAGE:0
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:78.27,NPI:6.168,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:84,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:11.06666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0664,GRADE:3,COHORT:1,PATIENT_ID:MB-0664,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:56.96,NPI:4.048,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:24,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:72.26666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0446,GRADE:3,COHORT:1,PATIENT_ID:MB-0446,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:76.97,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:41.36666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0008,GRADE:3,COHORT:1,PATIENT_ID:MB-0008,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:35.9,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:100,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:19.03333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-0656,GRADE:3,COHORT:1,PATIENT_ID:MB-0656,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:62.46,NPI:3.024,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:12,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:114.7666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0154,GRADE:2,COHORT:1,PATIENT_ID:MB-0154,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:64.55,NPI:4.034,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:113.0666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0597,GRADE:2,COHORT:1,PATIENT_ID:MB-0597,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:60.12,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:132.3333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0550,GRADE:2,COHORT:1,PATIENT_ID:MB-0550,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:75.98,NPI:5.076,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:38,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:29.03333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0616,GRADE:3,COHORT:1,PATIENT_ID:MB-0616,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:54.06,NPI:5.038,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:19,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:136.1666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-0412,GRADE:3,COHORT:1,PATIENT_ID:MB-0412,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:58.95,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:138.9,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:OTHER,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0122,GRADE:1,COHORT:1,PATIENT_ID:MB-0122,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:83.17,NPI:5.044,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0425,GRADE:2,COHORT:1,PATIENT_ID:MB-0425,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:73.48,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:4.433333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-0314,GRADE:3,COHORT:1,PATIENT_ID:MB-0314,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:58.16,NPI:3.032,CELLULARITY:moderate,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:213.5,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0356,GRADE:2,COHORT:1,PATIENT_ID:MB-0356,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:56.73,NPI:5.052,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:100.8333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-0440,GRADE:3,COHORT:1,PATIENT_ID:MB-0440,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:56.41,NPI:6.084,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:42,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:43.2,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-0398,GRADE:3,COHORT:1,PATIENT_ID:MB-0398,TUMOR_STAGE:3
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:57.41,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:135.1666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-0438,GRADE:3,COHORT:1,PATIENT_ID:MB-0438,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:54.38,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:112.5666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0449,GRADE:1,COHORT:1,PATIENT_ID:MB-0449,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:57.56,NPI:4.028,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:14,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:55.76666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0162,GRADE:2,COHORT:1,PATIENT_ID:MB-0162,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:62.34,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:90,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:34.66666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-0593,GRADE:2,COHORT:1,PATIENT_ID:MB-0593,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:82.46,NPI:5.046,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:122.7,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0301,GRADE:3,COHORT:1,PATIENT_ID:MB-0301,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.98,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:105.9666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0628,GRADE:2,COHORT:1,PATIENT_ID:MB-0628,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:49.87,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:70,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:85.33333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-0106,GRADE:1,COHORT:1,PATIENT_ID:MB-0106,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:67.01,NPI:4.052,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:null,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:170.0333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0341,GRADE:2,COHORT:1,PATIENT_ID:MB-0341,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:54.29,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:80,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:111.1,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0474,GRADE:3,COHORT:1,PATIENT_ID:MB-0474,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:56.48,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:64.23333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-MUC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-0394,GRADE:2,COHORT:1,PATIENT_ID:MB-0394,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:63.31,NPI:5.048,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:24,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:27.0,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-0373,GRADE:3,COHORT:1,PATIENT_ID:MB-0373,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:66.75,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:185.6,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0247,GRADE:2,COHORT:1,PATIENT_ID:MB-0247,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:59.15,NPI:3.038,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:19,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:212.2,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-0225,GRADE:2,COHORT:1,PATIENT_ID:MB-0225,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:44.02,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:60,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:9.833333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER-,name:MB-0424,GRADE:3,COHORT:1,PATIENT_ID:MB-0424,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:67.17,NPI:3.006,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:3,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:82.36666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0209,GRADE:2,COHORT:1,PATIENT_ID:MB-0209,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:39.84,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:66.73333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-0115,GRADE:3,COHORT:1,PATIENT_ID:MB-0115,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:72.3,NPI:3.026,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:13,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:88.2,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0136,GRADE:2,COHORT:1,PATIENT_ID:MB-0136,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:39.3,NPI:6.046,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:48.6,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:1,name:MB-0542,GRADE:3,COHORT:1,PATIENT_ID:MB-0542,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:73.01,NPI:5.034,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-0354,GRADE:3,COHORT:1,PATIENT_ID:MB-0354,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:67.7,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:49.23333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-0151,GRADE:3,COHORT:1,PATIENT_ID:MB-0151,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:60.27,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:72.46666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0590,GRADE:3,COHORT:1,PATIENT_ID:MB-0590,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:76.81,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:63.96666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-MED,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0608,GRADE:3,COHORT:1,PATIENT_ID:MB-0608,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:58.65,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:100,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:30.43333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:null,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0657,GRADE:2,COHORT:1,PATIENT_ID:MB-0657,TUMOR_STAGE:2
name:MTS-T0086
name:MTS-T0087
name:MTS-T0088
name:MTS-T0089
name:MTS-T0090
name:MTS-T0091
name:MTS-T0092
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:47.71,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:161.7666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:7,name:MB-0559,GRADE:3,COHORT:1,PATIENT_ID:MB-0559,TUMOR_STAGE:2
name:MTS-T0093
name:MTS-T0094
name:MTS-T0095
name:MTS-T0327
name:MTS-T2430
name:MTS-T2431
name:MTS-T2432
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:57.41,NPI:5.056,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:28,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:175.6333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0893,GRADE:3,COHORT:1,PATIENT_ID:MB-0893,TUMOR_STAGE:2
name:MTS-T0328
name:MTS-T0329
name:MTS-T0330
name:MTS-T0331
name:MTS-T0332
name:MTS-T0333
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:42.89,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-0514,GRADE:2,COHORT:1,PATIENT_ID:MB-0514,TUMOR_STAGE:2
name:MTS-T0334
name:MTS-T0335
name:MTS-T0336
name:MTS-T0337
name:MTS-T0338
name:MTS-T0339
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:80.38,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:29.0,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-0395,GRADE:3,COHORT:1,PATIENT_ID:MB-0395,TUMOR_STAGE:2
name:MTS-T0340
name:MTS-T0341
name:MTS-T0342
name:MTS-T0343
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:46.17,NPI:3.028,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:14,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:72.9,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-0294,GRADE:2,COHORT:1,PATIENT_ID:MB-0294,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:50.32,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:112.1333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-MUC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0439,GRADE:2,COHORT:1,PATIENT_ID:MB-0439,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:54.22,NPI:4.038,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:19,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:36.4,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0481,GRADE:3,COHORT:1,PATIENT_ID:MB-0481,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:67.46,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:48.53333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0529,GRADE:2,COHORT:1,PATIENT_ID:MB-0529,TUMOR_STAGE:4
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:44.01,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:176.7666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-0224,GRADE:3,COHORT:1,PATIENT_ID:MB-0224,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:81.53,NPI:6.058,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:29,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:84.2,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0302,GRADE:3,COHORT:1,PATIENT_ID:MB-0302,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.95,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:127.6333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0126,GRADE:2,COHORT:1,PATIENT_ID:MB-0126,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:37.24,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:39.83333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-0220,GRADE:3,COHORT:1,PATIENT_ID:MB-0220,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:62.55,NPI:2.026,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:13,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:144.6333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0192,GRADE:1,COHORT:1,PATIENT_ID:MB-0192,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:78.73,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:152.2,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0121,GRADE:2,COHORT:1,PATIENT_ID:MB-0121,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:77.85,NPI:2.092,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:46,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:85.56666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0239,GRADE:1,COHORT:1,PATIENT_ID:MB-0239,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:48.67,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:176.6,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-0364,GRADE:2,COHORT:1,PATIENT_ID:MB-0364,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:44.73,NPI:3.028,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:14,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:207.6333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-0232,GRADE:2,COHORT:1,PATIENT_ID:MB-0232,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:56.47,NPI:6.046,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:93.66666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0884,GRADE:3,COHORT:1,PATIENT_ID:MB-0884,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:52.19,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:193.1666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0238,GRADE:3,COHORT:1,PATIENT_ID:MB-0238,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:56.45,NPI:5.042,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:91.6,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0194,GRADE:2,COHORT:1,PATIENT_ID:MB-0194,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:73.39,NPI:4.094,CELLULARITY:moderate,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:47,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:42.36666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0882,GRADE:3,COHORT:1,PATIENT_ID:MB-0882,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:78.77,NPI:4.062,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:31,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0010,GRADE:3,COHORT:1,PATIENT_ID:MB-0010,TUMOR_STAGE:4
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:43.63,NPI:4.054,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:27,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:205.0333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-0236,GRADE:3,COHORT:1,PATIENT_ID:MB-0236,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.25,NPI:3.024,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:12,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:134.3666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0377,GRADE:2,COHORT:1,PATIENT_ID:MB-0377,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:76.89,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:114.2333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-0123,GRADE:3,COHORT:1,PATIENT_ID:MB-0123,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:68.16,NPI:4.042,CELLULARITY:moderate,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:130.4666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0504,GRADE:3,COHORT:1,PATIENT_ID:MB-0504,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:54.15,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:130.7,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0475,GRADE:3,COHORT:1,PATIENT_ID:MB-0475,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:46.86,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:174.6333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-0321,GRADE:3,COHORT:1,PATIENT_ID:MB-0321,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:39.53,NPI:5.032,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:24.86666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-0482,GRADE:3,COHORT:1,PATIENT_ID:MB-0482,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:46.89,NPI:3.068,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:34,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:148.0333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-0101,GRADE:2,COHORT:1,PATIENT_ID:MB-0101,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:50.94,NPI:4.028,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:14,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:69.8,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-0662,GRADE:3,COHORT:1,PATIENT_ID:MB-0662,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:51.19,NPI:5.052,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:39.2,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-0291,GRADE:3,COHORT:1,PATIENT_ID:MB-0291,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:87.18,NPI:5.052,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-0465,GRADE:3,COHORT:1,PATIENT_ID:MB-0465,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:38.35,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:86.8,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:1,name:MB-0630,GRADE:3,COHORT:1,PATIENT_ID:MB-0630,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:85.49,NPI:3.044,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:132.0333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0036,GRADE:2,COHORT:1,PATIENT_ID:MB-0036,TUMOR_STAGE:4
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:44.98,NPI:5.048,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:24,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:104.4,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-0166,GRADE:3,COHORT:1,PATIENT_ID:MB-0166,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:51.69,NPI:3.036,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:62.33333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0180,GRADE:2,COHORT:1,PATIENT_ID:MB-0180,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:48.47,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:65.86666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER-,name:MB-0525,GRADE:3,COHORT:1,PATIENT_ID:MB-0525,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:41.63,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:177.3333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-0307,GRADE:3,COHORT:1,PATIENT_ID:MB-0307,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:43.19,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:84.63333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-0002,GRADE:3,COHORT:1,PATIENT_ID:MB-0002,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:33.97,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:70,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:43.86666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:1,name:MB-0466,GRADE:2,COHORT:1,PATIENT_ID:MB-0466,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:51.92,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:56.5,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0632,GRADE:2,COHORT:1,PATIENT_ID:MB-0632,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:72.1,NPI:5.052,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:29.06666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0120,GRADE:3,COHORT:1,PATIENT_ID:MB-0120,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:58.71,NPI:4.036,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0507,GRADE:3,COHORT:1,PATIENT_ID:MB-0507,TUMOR_STAGE:1
name:MTS-T0344
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:77.54,NPI:4.038,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:null,TUMOR_SIZE:19,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:94.73333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0287,GRADE:2,COHORT:1,PATIENT_ID:MB-0287,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:58.83,NPI:4.058,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:29,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:112.4,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0869,GRADE:3,COHORT:1,PATIENT_ID:MB-0869,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:67.03,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:318.2,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4633,GRADE:3,COHORT:3,PATIENT_ID:MB-4633,TUMOR_STAGE:2
name:MTS-T0345
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:55.65,CELLULARITY:moderate,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:186.6333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4627,GRADE:3,COHORT:3,PATIENT_ID:MB-4627,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.16,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:256.8666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-4004,GRADE:3,COHORT:3,PATIENT_ID:MB-4004,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.03,NPI:4.036,CELLULARITY:moderate,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:227.9,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4708,GRADE:3,COHORT:3,PATIENT_ID:MB-4708,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:40.05,NPI:3.024,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:12,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:267.4,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:1,name:MB-4618,GRADE:2,COHORT:3,PATIENT_ID:MB-4618,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:64.93,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:148.5666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4641,GRADE:3,COHORT:3,PATIENT_ID:MB-4641,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:40.83,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:282.8333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-4622,GRADE:3,COHORT:3,PATIENT_ID:MB-4622,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:66.37,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:109.6,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4634,GRADE:3,COHORT:3,PATIENT_ID:MB-4634,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:71.17,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:45,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:85.3,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-4688,GRADE:2,COHORT:3,PATIENT_ID:MB-4688,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:54.27,NPI:4.036,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:260.2,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4665,GRADE:3,COHORT:3,PATIENT_ID:MB-4665,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:57.98,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:111.5666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4666,GRADE:3,COHORT:3,PATIENT_ID:MB-4666,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:61.59,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:200.6,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4640,GRADE:3,COHORT:3,PATIENT_ID:MB-4640,TUMOR_STAGE:2
name:MTS-T0346
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:49.76,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:282.5666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:7,name:MB-4691,GRADE:3,COHORT:3,PATIENT_ID:MB-4691,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:72.48,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:34.7,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-4671,GRADE:3,COHORT:3,PATIENT_ID:MB-4671,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:65.58,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:295.3333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-4667,GRADE:3,COHORT:3,PATIENT_ID:MB-4667,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:66.39,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:60,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:23.73333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4721,GRADE:1,COHORT:3,PATIENT_ID:MB-4721,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:64.76,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:211.9666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-4723,GRADE:3,COHORT:3,PATIENT_ID:MB-4723,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:44.27,NPI:2.198,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:99,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:198.3333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-4718,GRADE:1,COHORT:3,PATIENT_ID:MB-4718,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:52.98,NPI:4.056,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:28,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:76.13333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4716,GRADE:3,COHORT:3,PATIENT_ID:MB-4716,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:75.41,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:28.0,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-4729,GRADE:3,COHORT:3,PATIENT_ID:MB-4729,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:43.51,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:42.9,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-4717,GRADE:3,COHORT:3,PATIENT_ID:MB-4717,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:60.44,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:146.0666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-4724,GRADE:3,COHORT:3,PATIENT_ID:MB-4724,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:70.22,NPI:4.026,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:13,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:152.0666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-4770,GRADE:3,COHORT:3,PATIENT_ID:MB-4770,TUMOR_STAGE:1
name:MTS-T0347
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.7,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:60,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:125.2666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-4752,GRADE:2,COHORT:3,PATIENT_ID:MB-4752,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:67.82,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:252.1,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4762,GRADE:2,COHORT:3,PATIENT_ID:MB-4762,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:62.84,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:51.96666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-5169,GRADE:3,COHORT:3,PATIENT_ID:MB-5169,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:53.18,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:128.2666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-4796,GRADE:2,COHORT:3,PATIENT_ID:MB-4796,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:43.73,NPI:3.056,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:28,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:70.46666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:7,name:MB-4790,GRADE:2,COHORT:3,PATIENT_ID:MB-4790,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:81.06,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:99.36666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-4797,GRADE:2,COHORT:3,PATIENT_ID:MB-4797,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:61.3,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:110.9333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-4800,GRADE:3,COHORT:3,PATIENT_ID:MB-4800,TUMOR_STAGE:2
name:MB-5541
name:MB-5549
name:MTS-T0348
name:MB-5519
name:MB-5495
name:MTS-T0349
name:MTS-T0350
name:MTS-T0351
name:MTS-T0352
name:MTS-T0353
name:MTS-T0354
name:MTS-T0355
name:MTS-T0356
name:MTS-T0357
name:MTS-T0358
name:MTS-T0359
name:MTS-T0360
name:MTS-T0361
name:MTS-T0362
name:MTS-T0363
name:MTS-T0364
name:MTS-T0365
name:MTS-T0366
name:MTS-T0367
name:MTS-T0368
name:MTS-T0369
name:MTS-T0370
name:MTS-T0371
name:MTS-T0372
name:MTS-T0373
name:MTS-T0374
name:MTS-T0375
name:MTS-T0376
name:MTS-T0377
name:MTS-T0378
name:MTS-T0379
name:MTS-T0380
name:MTS-T0381
name:MTS-T0382
name:MTS-T0383
name:MTS-T0384
name:MTS-T0385
name:MTS-T0386
name:MTS-T0387
name:MTS-T0388
name:MTS-T0389
name:MTS-T0390
name:MTS-T0391
name:MTS-T0392
name:MTS-T0393
name:MTS-T0394
name:MTS-T0395
name:MTS-T0396
name:MTS-T0397
name:MTS-T0398
name:MTS-T0399
name:MTS-T0400
name:MTS-T0401
name:MTS-T0402
name:MTS-T0403
name:MTS-T0404
name:MTS-T0405
name:MTS-T0406
name:MTS-T0407
name:MTS-T0408
name:MTS-T0273
name:MTS-T0275
name:MTS-T0276
name:MB-0025
name:MTS-T0281
name:MTS-T0285
name:MTS-T0286
name:MTS-T0299
name:MTS-T0279
name:MTS-T0303
name:MTS-T0304
name:MTS-T0305
name:MTS-T0312
name:MTS-T0313
name:MTS-T0325
name:MTS-T0235
name:MTS-T2190
name:MTS-T0237
name:MTS-T0238
name:MTS-T0239
name:MTS-T0240
name:MTS-T0241
name:MTS-T0242
name:MTS-T0927
name:MTS-T2206
name:MTS-T0602
name:MTS-T0951
name:MTS-T2167
name:MTS-T0600
name:MTS-T0249
name:MTS-T2212
name:MTS-T0243
name:MTS-T0244
name:MTS-T0245
name:MTS-T0246
name:MTS-T0248
name:MB-0326
name:MB-0329
name:MTS-T0251
name:MTS-T0253
name:MTS-T1269
name:MTS-T1270
name:MTS-T1272
name:MTS-T1278
name:MTS-T0247
name:MTS-T2418
name:MTS-T1020
name:MB-0547
name:MTS-T0254
name:MTS-T2419
name:MTS-T0255
name:MTS-T2420
name:MTS-T2421
name:MTS-T1000
name:MTS-T2422
name:MTS-T1047
name:MTS-T2423
name:MTS-T0257
name:MTS-T2424
name:MTS-T1240
name:MTS-T2426
name:MTS-T0259
name:MTS-T0163
name:MTS-T0164
name:MTS-T0161
name:MTS-T0035
name:MTS-T0188
name:MTS-T0189
name:MTS-T0190
name:MTS-T0191
name:MTS-T0192
name:MTS-T0193
name:MTS-T0194
name:MTS-T0195
name:MTS-T0196
name:MTS-T1800
name:MTS-T0197
name:MTS-T0198
name:MTS-T1847
name:MTS-T0199
name:MTS-T0200
name:MTS-T0201
name:MTS-T1138
name:MTS-T1134
name:MTS-T0202
name:MTS-T0203
name:MTS-T0204
name:MTS-T0205
name:MTS-T0206
name:MTS-T0207
name:MTS-T0208
name:MTS-T0209
name:MTS-T0210
name:MTS-T0211
name:MTS-T0212
name:MTS-T0213
name:MTS-T1223
name:MTS-T0214
name:MTS-T0215
name:MTS-T0216
name:MTS-T0217
name:MTS-T0218
name:MTS-T0219
name:MTS-T0220
name:MTS-T0221
name:MTS-T1829
name:MTS-T1248
name:MTS-T0222
name:MTS-T0223
name:MTS-T0224
name:MTS-T0225
name:MTS-T0226
name:MTS-T1191
name:MTS-T0227
name:MTS-T0266
name:MTS-T0228
name:MTS-T0229
name:MTS-T0230
name:MTS-T0231
name:MTS-T1189
name:MTS-T1213
name:MTS-T1774
name:MTS-T0232
name:MTS-T1259
name:MTS-T0233
name:MTS-T0234
name:MTS-T0162
name:MTS-T0178
name:MTS-T0179
name:MTS-T0180
name:MTS-T1203
name:MTS-T0181
name:MTS-T2320
name:MTS-T0165
name:MTS-T0166
name:MTS-T1706
name:MTS-T0182
name:MTS-T0167
name:MTS-T0168
name:MTS-T2291
name:MTS-T0169
name:MTS-T2191
name:MTS-T0187
name:MTS-T0673
name:MTS-T0186
name:MTS-T0177
name:MTS-T2304
name:MTS-T0170
name:MTS-T0171
name:MTS-T0172
name:MTS-T0173
name:MTS-T0174
name:MTS-T0685
name:MTS-T2150
name:MTS-T2428
name:MTS-T2429
name:MTS-T0175
name:MTS-T2189
name:MTS-T0183
name:MTS-T0184
name:MTS-T0185
name:MTS-T0911
name:MTS-T2178
name:MTS-T2153
name:MTS-T0646
name:MTS-T2073
name:MTS-T2083
name:MTS-T2104
name:MTS-T2094
name:MTS-T2115
name:MTS-T2095
name:MTS-T2084
name:MTS-T2105
name:MTS-T2075
name:MTS-T2127
name:MTS-T2054
name:MTS-T2065
name:MTS-T2064
name:MTS-T2085
name:MTS-T2066
name:MTS-T2106
name:MTS-T2076
name:MTS-T2097
name:MTS-T2086
name:MTS-T2118
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:50.08,NPI:5.074,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:37,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:42.66666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-4745,GRADE:3,COHORT:3,PATIENT_ID:MB-4745,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:65.93,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:214.4333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4825,GRADE:2,COHORT:3,PATIENT_ID:MB-4825,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:39.92,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:73.46666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-4814,GRADE:2,COHORT:3,PATIENT_ID:MB-4814,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:38.93,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-4757,GRADE:3,COHORT:3,PATIENT_ID:MB-4757,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:76.06,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:198.3,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-4694,GRADE:3,COHORT:3,PATIENT_ID:MB-4694,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:59.18,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:170.6666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4698,GRADE:3,COHORT:3,PATIENT_ID:MB-4698,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:67.8,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:45,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:35.23333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4715,GRADE:3,COHORT:3,PATIENT_ID:MB-4715,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:73.6,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:43.3,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-4685,GRADE:3,COHORT:3,PATIENT_ID:MB-4685,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:46.59,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:249.5333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:9,name:MB-4712,GRADE:3,COHORT:3,PATIENT_ID:MB-4712,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:58.78,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:220.9333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4672,GRADE:3,COHORT:3,PATIENT_ID:MB-4672,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:67.79,NPI:4.098,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:49,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:64.0,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4704,GRADE:3,COHORT:3,PATIENT_ID:MB-4704,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:64.01,NPI:5.032,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:99.0,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4655,GRADE:3,COHORT:3,PATIENT_ID:MB-4655,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.96,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-4651,GRADE:2,COHORT:3,PATIENT_ID:MB-4651,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:81.11,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:234.2333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4661,GRADE:2,COHORT:3,PATIENT_ID:MB-4661,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.67,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:16.83333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4649,GRADE:2,COHORT:3,PATIENT_ID:MB-4649,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:66.27,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:285.7,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-4642,GRADE:3,COHORT:3,PATIENT_ID:MB-4642,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:75.26,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:81.06666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4674,GRADE:2,COHORT:3,PATIENT_ID:MB-4674,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:75.19,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:168.5333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-4648,GRADE:3,COHORT:3,PATIENT_ID:MB-4648,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:62.11,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:223.8333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-5197,GRADE:2,COHORT:3,PATIENT_ID:MB-5197,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:76.19,NPI:4.034,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:115.9333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-5152,GRADE:2,COHORT:3,PATIENT_ID:MB-5152,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:73.17,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:96.96666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-5201,GRADE:2,COHORT:3,PATIENT_ID:MB-5201,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.24,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:111.9666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-5189,GRADE:3,COHORT:3,PATIENT_ID:MB-5189,TUMOR_STAGE:2
name:MB-5281
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:80.17,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:179.1,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-5212,GRADE:3,COHORT:3,PATIENT_ID:MB-5212,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:49.57,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:184.2666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-5172,GRADE:3,COHORT:3,PATIENT_ID:MB-5172,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:74.34,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:118.5333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-5183,GRADE:2,COHORT:3,PATIENT_ID:MB-5183,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.88,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:77.46666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-5185,GRADE:3,COHORT:3,PATIENT_ID:MB-5185,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.93,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:213.3666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-5014,GRADE:3,COHORT:3,PATIENT_ID:MB-5014,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:77.54,NPI:3.044,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:174.1333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4994,GRADE:2,COHORT:3,PATIENT_ID:MB-4994,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:65.86,NPI:6.028,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:14,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:144.9333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-5017,GRADE:3,COHORT:3,PATIENT_ID:MB-5017,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:62.99,NPI:6.034,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:19.16666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4982,GRADE:3,COHORT:3,PATIENT_ID:MB-4982,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:42.84,NPI:5.074,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:37,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:216.7333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER-,name:MB-5004,GRADE:3,COHORT:3,PATIENT_ID:MB-5004,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:41.0,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:79.8,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:9,name:MB-4986,GRADE:2,COHORT:3,PATIENT_ID:MB-4986,TUMOR_STAGE:2
name:MB-5327
name:MB-5341
name:MB-5323
name:MB-5328
name:MB-5318
name:MB-5287
name:MB-5324
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:65.5,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:139.5333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-4682,GRADE:3,COHORT:3,PATIENT_ID:MB-4682,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:77.12,NPI:4.038,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:19,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:57.66666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4710,GRADE:3,COHORT:3,PATIENT_ID:MB-4710,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:47.62,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:127.5333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-4701,GRADE:3,COHORT:3,PATIENT_ID:MB-4701,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:49.02,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:146.7666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-4709,GRADE:2,COHORT:3,PATIENT_ID:MB-4709,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:53.03,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:48.43333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4686,GRADE:3,COHORT:3,PATIENT_ID:MB-4686,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:75.48,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:55.66666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4706,GRADE:3,COHORT:3,PATIENT_ID:MB-4706,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:67.27,NPI:5.044,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:81.56666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4719,GRADE:2,COHORT:3,PATIENT_ID:MB-4719,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:52.13,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:300.8666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-4702,GRADE:3,COHORT:3,PATIENT_ID:MB-4702,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:69.87,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:47.9,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-4908,GRADE:3,COHORT:3,PATIENT_ID:MB-4908,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:74.53,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:39.8,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-4871,GRADE:2,COHORT:3,PATIENT_ID:MB-4871,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:73.03,NPI:3.052,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:233.8666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-4906,GRADE:1,COHORT:3,PATIENT_ID:MB-4906,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:43.51,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:31.43333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-4911,GRADE:3,COHORT:3,PATIENT_ID:MB-4911,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:43.86,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:224.3,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-4866,GRADE:1,COHORT:3,PATIENT_ID:MB-4866,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:74.56,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:129.3333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-4858,GRADE:3,COHORT:3,PATIENT_ID:MB-4858,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:64.32,NPI:4.046,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:187.3,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-4862,GRADE:3,COHORT:3,PATIENT_ID:MB-4862,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:58.69,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:157.1,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4872,GRADE:2,COHORT:3,PATIENT_ID:MB-4872,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:52.09,NPI:5.066,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:33,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:35.4,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4887,GRADE:3,COHORT:3,PATIENT_ID:MB-4887,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:47.03,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:221.9,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-4867,GRADE:2,COHORT:3,PATIENT_ID:MB-4867,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.95,NPI:4.032,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:230.5,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-4888,GRADE:3,COHORT:3,PATIENT_ID:MB-4888,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:59.49,NPI:6.052,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:40.0,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-4929,GRADE:3,COHORT:3,PATIENT_ID:MB-4929,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:65.53,NPI:5.038,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:19,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:20.13333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-4945,GRADE:3,COHORT:3,PATIENT_ID:MB-4945,TUMOR_STAGE:null
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:62.43,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:58.43333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-4930,GRADE:3,COHORT:3,PATIENT_ID:MB-4930,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:47.71,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:232.4,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-4894,GRADE:3,COHORT:3,PATIENT_ID:MB-4894,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.63,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:117.9,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4898,GRADE:2,COHORT:3,PATIENT_ID:MB-4898,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.0,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:67.8,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4670,GRADE:2,COHORT:3,PATIENT_ID:MB-4670,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:68.56,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:251.2,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-5013,GRADE:2,COHORT:3,PATIENT_ID:MB-5013,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:72.54,NPI:6.044,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:216.7333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4977,GRADE:3,COHORT:3,PATIENT_ID:MB-4977,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.16,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:130.7,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4967,GRADE:2,COHORT:3,PATIENT_ID:MB-4967,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.67,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:180.7666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4981,GRADE:3,COHORT:3,PATIENT_ID:MB-4981,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:70.31,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:106.5666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-4003,GRADE:2,COHORT:3,PATIENT_ID:MB-4003,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:56.03,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:78.7,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4968,GRADE:2,COHORT:3,PATIENT_ID:MB-4968,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:76.66,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:34.56666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-5052,GRADE:3,COHORT:3,PATIENT_ID:MB-5052,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.76,NPI:3.034,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:255.3,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-5049,GRADE:2,COHORT:3,PATIENT_ID:MB-5049,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:45.4,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:173.9333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:2,name:MB-5041,GRADE:3,COHORT:3,PATIENT_ID:MB-5041,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:55.56,NPI:3.034,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:139.4333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-5044,GRADE:2,COHORT:3,PATIENT_ID:MB-5044,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:52.23,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:50.23333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-5072,GRADE:3,COHORT:3,PATIENT_ID:MB-5072,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:64.21,NPI:4.086,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:43,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:184.7,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-4171,GRADE:3,COHORT:3,PATIENT_ID:MB-4171,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:68.21,NPI:3.042,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:150.6,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-5053,GRADE:2,COHORT:3,PATIENT_ID:MB-5053,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:70.11,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:168.3,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-5045,GRADE:3,COHORT:3,PATIENT_ID:MB-5045,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:74.71,NPI:5.036,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:71.76666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-5116,GRADE:2,COHORT:3,PATIENT_ID:MB-5116,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:47.24,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-5120,GRADE:3,COHORT:3,PATIENT_ID:MB-5120,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:70.59,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:221.6,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-5074,GRADE:3,COHORT:3,PATIENT_ID:MB-5074,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:75.33,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:59.76666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-5119,GRADE:2,COHORT:3,PATIENT_ID:MB-5119,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:57.87,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:15.36666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-5114,GRADE:3,COHORT:3,PATIENT_ID:MB-5114,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:75.87,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:115.6,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4230,GRADE:2,COHORT:3,PATIENT_ID:MB-4230,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:54.22,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:49.56666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4154,GRADE:3,COHORT:3,PATIENT_ID:MB-4154,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:40.57,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:77.4,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-5115,GRADE:3,COHORT:3,PATIENT_ID:MB-5115,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:52.29,NPI:5.092,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:46,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:122.2,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-4737,GRADE:3,COHORT:3,PATIENT_ID:MB-4737,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:57.95,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:245.5,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4764,GRADE:3,COHORT:3,PATIENT_ID:MB-4764,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:54.18,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:297.8,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4735,GRADE:2,COHORT:3,PATIENT_ID:MB-4735,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:51.29,NPI:4.136,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:68,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:131.3,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4730,GRADE:3,COHORT:3,PATIENT_ID:MB-4730,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:56.27,NPI:6.036,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:19.73333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-4733,GRADE:3,COHORT:3,PATIENT_ID:MB-4733,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:45.77,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:211.9333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-4758,GRADE:3,COHORT:3,PATIENT_ID:MB-4758,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.92,NPI:2.086,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:43,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:52.73333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-MUC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-5033,GRADE:1,COHORT:3,PATIENT_ID:MB-5033,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:53.02,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:56.5,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4741,GRADE:2,COHORT:3,PATIENT_ID:MB-4741,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:26.72,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:45,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:149.8666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-4732,GRADE:3,COHORT:3,PATIENT_ID:MB-4732,TUMOR_STAGE:2
name:MB-5305
name:MB-5256
name:MB-5273
name:MB-5236
name:MB-5238
name:MB-5233
name:MB-5244
name:MB-5253
name:MB-5260
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:75.27,NPI:6.064,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:32,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:65.56666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4998,GRADE:3,COHORT:3,PATIENT_ID:MB-4998,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:33.55,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:75.23333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER-,name:MB-4993,GRADE:3,COHORT:3,PATIENT_ID:MB-4993,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:71.61,NPI:4.042,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:81.8,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-5001,GRADE:2,COHORT:3,PATIENT_ID:MB-5001,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:49.0,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:198.1,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-5084,GRADE:2,COHORT:3,PATIENT_ID:MB-5084,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:76.81,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:198.1,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4969,GRADE:2,COHORT:3,PATIENT_ID:MB-4969,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:44.84,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:187.9333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:7,name:MB-4999,GRADE:2,COHORT:3,PATIENT_ID:MB-4999,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:67.68,NPI:3.046,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:80.5,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-5011,GRADE:2,COHORT:3,PATIENT_ID:MB-5011,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:76.93,NPI:2.026,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:13,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:117.5666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4959,GRADE:1,COHORT:3,PATIENT_ID:MB-4959,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.83,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:191.1666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4599,GRADE:3,COHORT:3,PATIENT_ID:MB-4599,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:71.47,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:90.13333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4616,GRADE:2,COHORT:3,PATIENT_ID:MB-4616,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.88,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:292.0333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4623,GRADE:2,COHORT:3,PATIENT_ID:MB-4623,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:59.13,NPI:4.046,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:90.0,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-4644,GRADE:2,COHORT:3,PATIENT_ID:MB-4644,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:67.12,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4869,GRADE:2,COHORT:3,PATIENT_ID:MB-4869,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:79.35,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:22.46666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-4878,GRADE:2,COHORT:3,PATIENT_ID:MB-4878,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:73.95,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:90.26666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-4851,GRADE:2,COHORT:3,PATIENT_ID:MB-4851,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:54.01,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:36.36666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-4233,GRADE:2,COHORT:3,PATIENT_ID:MB-4233,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:41.09,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:77.23333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:6,name:MB-4937,GRADE:3,COHORT:3,PATIENT_ID:MB-4937,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:74.85,NPI:5.056,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:28,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:70.23333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4934,GRADE:2,COHORT:3,PATIENT_ID:MB-4934,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:40.25,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:275.7333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-4899,GRADE:2,COHORT:3,PATIENT_ID:MB-4899,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:78.19,NPI:4.056,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:28,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:50.0,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4912,GRADE:2,COHORT:3,PATIENT_ID:MB-4912,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:36.35,NPI:5.046,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:194.2,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-4935,GRADE:3,COHORT:3,PATIENT_ID:MB-4935,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:50.78,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:272.9,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4933,GRADE:2,COHORT:3,PATIENT_ID:MB-4933,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:47.61,NPI:3.036,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:224.6,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:6,name:MB-4900,GRADE:2,COHORT:3,PATIENT_ID:MB-4900,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:57.32,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:58.63333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4941,GRADE:2,COHORT:3,PATIENT_ID:MB-4941,TUMOR_STAGE:1
name:MB-5221
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:69.16,NPI:6.058,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:29,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:89.96666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-5139,GRADE:3,COHORT:3,PATIENT_ID:MB-5139,TUMOR_STAGE:2
name:MB-5222
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:56.33,NPI:3.044,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:61.6,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-5097,GRADE:2,COHORT:3,PATIENT_ID:MB-5097,TUMOR_STAGE:2
name:MB-5338
name:MB-5315
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:72.16,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:196.8666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-5195,GRADE:3,COHORT:3,PATIENT_ID:MB-5195,TUMOR_STAGE:1
name:MB-5226
name:MB-5232
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:68.52,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:87.73333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-5160,GRADE:2,COHORT:3,PATIENT_ID:MB-5160,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.48,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:null,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-5126,GRADE:3,COHORT:3,PATIENT_ID:MB-5126,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:83.96,NPI:3.052,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:124.2,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-5124,GRADE:2,COHORT:3,PATIENT_ID:MB-5124,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:74.8,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:41.46666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4855,GRADE:3,COHORT:3,PATIENT_ID:MB-4855,TUMOR_STAGE:null
name:MB-5279
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:74.31,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:160.3333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4173,GRADE:2,COHORT:3,PATIENT_ID:MB-4173,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.55,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:159.2333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-5145,GRADE:3,COHORT:3,PATIENT_ID:MB-5145,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:77.77,NPI:3.036,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:237.2666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-4944,GRADE:2,COHORT:3,PATIENT_ID:MB-4944,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:56.94,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:219.4666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4961,GRADE:2,COHORT:3,PATIENT_ID:MB-4961,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:72.02,NPI:4.036,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:114.9,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-5121,GRADE:3,COHORT:3,PATIENT_ID:MB-5121,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.31,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:60,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:69.3,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-4956,GRADE:3,COHORT:3,PATIENT_ID:MB-4956,TUMOR_STAGE:3
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:43.42,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:45,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:48.16666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-4886,GRADE:3,COHORT:3,PATIENT_ID:MB-4886,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.99,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:150.6,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4950,GRADE:3,COHORT:3,PATIENT_ID:MB-4950,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.93,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:263.6,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4965,GRADE:2,COHORT:3,PATIENT_ID:MB-4965,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:72.44,NPI:4.028,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:14,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:197.8333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4962,GRADE:2,COHORT:3,PATIENT_ID:MB-4962,TUMOR_STAGE:null
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:67.15,NPI:4.042,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:184.4,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-4952,GRADE:3,COHORT:3,PATIENT_ID:MB-4952,TUMOR_STAGE:2
name:MB-5267
name:MB-5266
name:MB-5396
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:33.92,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:70.6,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-4938,GRADE:2,COHORT:3,PATIENT_ID:MB-4938,TUMOR_STAGE:2
name:MB-5351
name:MB-5347
name:MB-5312
name:MB-5311
name:MB-5284
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:57.85,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:63.03333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-4148,GRADE:2,COHORT:3,PATIENT_ID:MB-4148,TUMOR_STAGE:null
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:56.33,NPI:4.048,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:24,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:87.1,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-5078,GRADE:2,COHORT:3,PATIENT_ID:MB-5078,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:72.38,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:199.3666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-5088,GRADE:2,COHORT:3,PATIENT_ID:MB-5088,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:63.4,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:91.5,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-5064,GRADE:2,COHORT:3,PATIENT_ID:MB-5064,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:61.06,NPI:4.082,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:41,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:82.63333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-5107,GRADE:3,COHORT:3,PATIENT_ID:MB-5107,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:53.58,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:94.7,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-5066,GRADE:2,COHORT:3,PATIENT_ID:MB-5066,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:71.19,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:182.5,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-5068,GRADE:2,COHORT:3,PATIENT_ID:MB-5068,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:71.05,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:39.43333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-5061,GRADE:2,COHORT:3,PATIENT_ID:MB-5061,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:47.38,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:213.9,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-5070,GRADE:3,COHORT:3,PATIENT_ID:MB-5070,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:53.69,NPI:3.034,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:257.6333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-5059,GRADE:2,COHORT:3,PATIENT_ID:MB-5059,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:45,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:33.9,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:6,name:MB-4266,GRADE:3,COHORT:3,PATIENT_ID:MB-4266,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:55.07,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:132.2,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-4276,GRADE:2,COHORT:3,PATIENT_ID:MB-4276,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:47.86,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:297.2333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-4771,GRADE:2,COHORT:3,PATIENT_ID:MB-4771,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:56.08,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:161.6666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4739,GRADE:2,COHORT:3,PATIENT_ID:MB-4739,TUMOR_STAGE:1
name:MB-5331
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:52.61,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:230.1666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4743,GRADE:2,COHORT:3,PATIENT_ID:MB-4743,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:75.46,NPI:3.056,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:28,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:121.6666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4785,GRADE:2,COHORT:3,PATIENT_ID:MB-4785,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:78.62,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:206.1333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-MUC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4778,GRADE:2,COHORT:3,PATIENT_ID:MB-4778,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:44.07,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:102.1,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-4763,GRADE:3,COHORT:3,PATIENT_ID:MB-4763,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:53.39,NPI:4.026,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:13,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:101.5666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4779,GRADE:2,COHORT:3,PATIENT_ID:MB-4779,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:81.52,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:45.33333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4849,GRADE:3,COHORT:3,PATIENT_ID:MB-4849,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:68.85,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:81.06666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-4787,GRADE:2,COHORT:3,PATIENT_ID:MB-4787,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:74.86,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:47.13333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-4767,GRADE:3,COHORT:3,PATIENT_ID:MB-4767,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.35,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:145.7333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-4784,GRADE:3,COHORT:3,PATIENT_ID:MB-4784,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:70.42,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:128.3666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-5043,GRADE:3,COHORT:3,PATIENT_ID:MB-5043,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:66.47,NPI:3.066,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:33,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:165.3666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4992,GRADE:2,COHORT:3,PATIENT_ID:MB-4992,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:62.68,NPI:6.034,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:84.83333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-5020,GRADE:3,COHORT:3,PATIENT_ID:MB-5020,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:49.88,NPI:4.024,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:12,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:neg,OS_MONTHS:37.8,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-5019,GRADE:3,COHORT:3,PATIENT_ID:MB-5019,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:44.36,NPI:4.044,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:252.3,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-5015,GRADE:3,COHORT:3,PATIENT_ID:MB-5015,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:44.12,NPI:3.032,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:86.36666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:7,name:MB-5048,GRADE:2,COHORT:3,PATIENT_ID:MB-5048,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:56.47,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:55,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:213.2,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-5035,GRADE:3,COHORT:3,PATIENT_ID:MB-5035,TUMOR_STAGE:2
name:MB-5398
name:MB-5377
name:MB-5291
name:MB-5403
name:MB-5224
name:MB-5369
name:MB-5404
name:MB-5397
name:MB-5378
name:MB-5388
name:MB-5395
name:MB-5365
name:MB-5389
name:MB-5393
name:MB-5361
name:MB-5392
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:54.61,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:20.26666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-5147,GRADE:3,COHORT:3,PATIENT_ID:MB-5147,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:71.17,NPI:4.046,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:114.5,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4140,GRADE:3,COHORT:3,PATIENT_ID:MB-4140,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:44.59,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:37.0,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:null,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-5138,GRADE:3,COHORT:3,PATIENT_ID:MB-5138,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:69.72,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:90.3,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-5123,GRADE:2,COHORT:3,PATIENT_ID:MB-5123,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:68.66,NPI:4.032,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:184.8,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-5065,GRADE:3,COHORT:3,PATIENT_ID:MB-5065,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:54.35,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:258.1666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-4127,GRADE:3,COHORT:3,PATIENT_ID:MB-4127,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.04,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:178.7333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-5058,GRADE:3,COHORT:3,PATIENT_ID:MB-5058,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:55.04,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:184.3333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-5050,GRADE:2,COHORT:3,PATIENT_ID:MB-5050,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:46.95,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:189.8666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-5027,GRADE:3,COHORT:3,PATIENT_ID:MB-5027,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:75.01,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:150.1,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-5060,GRADE:2,COHORT:3,PATIENT_ID:MB-5060,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:75.55,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:168.2666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-5062,GRADE:3,COHORT:3,PATIENT_ID:MB-5062,TUMOR_STAGE:2
name:MB-5383
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:67.86,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:34.33333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-5101,GRADE:2,COHORT:3,PATIENT_ID:MB-5101,TUMOR_STAGE:3
name:MB-5258
name:MB-5268
name:MB-5261
name:MB-5272
name:MB-5264
name:MB-5259
name:MB-5306
name:MB-5270
name:MB-5411
name:MB-5490
name:MB-5421
name:MB-5348
name:MB-5429
name:MB-5405
name:MB-5414
name:MB-5489
name:MB-5417
name:MB-5481
name:MB-5409
name:MB-5299
name:MB-5408
name:MB-5475
name:MB-5505
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:32.74,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-5100,GRADE:3,COHORT:3,PATIENT_ID:MB-5100,TUMOR_STAGE:2
name:MB-5502
name:MB-5485
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:54.16,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:219.1666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4293,GRADE:2,COHORT:3,PATIENT_ID:MB-4293,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:65.49,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:96.83333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-4289,GRADE:1,COHORT:3,PATIENT_ID:MB-4289,TUMOR_STAGE:1
name:MB-5293
name:MB-5381
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:49.61,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:36.16666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:1,name:MB-4834,GRADE:3,COHORT:3,PATIENT_ID:MB-4834,TUMOR_STAGE:null
name:MB-5498
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:70.57,NPI:4.044,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:51.46666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4749,GRADE:3,COHORT:3,PATIENT_ID:MB-4749,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:75.74,NPI:4.114,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:57,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:76.23333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4818,GRADE:2,COHORT:3,PATIENT_ID:MB-4818,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:45.39,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:129.8,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:7,name:MB-4805,GRADE:3,COHORT:3,PATIENT_ID:MB-4805,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:43.77,NPI:4.028,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:14,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:286.0666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-4809,GRADE:3,COHORT:3,PATIENT_ID:MB-4809,TUMOR_STAGE:1
name:MB-5418
name:MB-5441
name:MB-5424
name:MB-5296
name:MB-5446
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.95,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:142.4333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-5093,GRADE:2,COHORT:3,PATIENT_ID:MB-5093,TUMOR_STAGE:2
name:MB-5350
name:MB-5230
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:67.45,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:205.7333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-MUC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-5206,GRADE:2,COHORT:3,PATIENT_ID:MB-5206,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:81.98,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:74.1,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4687,GRADE:3,COHORT:3,PATIENT_ID:MB-4687,TUMOR_STAGE:2
name:MB-5433
name:MB-5442
name:MB-5427
name:MB-5491
name:MB-5493
name:MB-5451
name:MB-5454
name:MB-5360
name:MB-5229
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:78.54,NPI:3.044,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:45.7,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4827,GRADE:2,COHORT:3,PATIENT_ID:MB-4827,TUMOR_STAGE:2
name:MB-5455
name:MB-5370
name:MB-5290
name:MB-5366
name:MB-5382
name:MB-5402
name:MB-5288
name:MB-5384
name:MB-5358
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:77.12,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:114.0333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4357,GRADE:3,COHORT:3,PATIENT_ID:MB-4357,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:77.13,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:126.8666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-4991,GRADE:3,COHORT:3,PATIENT_ID:MB-4991,TUMOR_STAGE:2
name:MB-5401
name:MB-5390
name:MB-5412
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:88.8,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:54.26666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:OTHER,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-5193,GRADE:1,COHORT:3,PATIENT_ID:MB-5193,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:78.04,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:134.2666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-5182,GRADE:3,COHORT:3,PATIENT_ID:MB-5182,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:70.68,NPI:6.024,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:12,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:18.23333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-5157,GRADE:3,COHORT:3,PATIENT_ID:MB-5157,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:50.24,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:185.3,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-5205,GRADE:3,COHORT:3,PATIENT_ID:MB-5205,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:44.41,NPI:3.024,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:12,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:175.3333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-5161,GRADE:2,COHORT:3,PATIENT_ID:MB-5161,TUMOR_STAGE:1
name:MB-5292
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:68.42,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:247.8333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-5211,GRADE:3,COHORT:3,PATIENT_ID:MB-5211,TUMOR_STAGE:2
HER2_SNP6:NEUT,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,AGE_AT_DIAGNOSIS:42.11,THREEGENE:ER+/HER2- High Prolif,CELLULARITY:high,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,HORMONE_THERAPY:NO,LATERALITY:l,INTCLUST:1,name:MB-5218,COHORT:3,ER_IHC:pos,OS_MONTHS:254.9666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:79.17,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:60,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:175.1,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-5209,GRADE:3,COHORT:3,PATIENT_ID:MB-5209,TUMOR_STAGE:2
name:MB-5227
HER2_SNP6:GAIN,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,AGE_AT_DIAGNOSIS:74.98,THREEGENE:HER2+,CELLULARITY:high,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,HORMONE_THERAPY:YES,LATERALITY:l,INTCLUST:5,name:MB-5213,COHORT:3,ER_IHC:neg,OS_MONTHS:43.4,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:69.23,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:80.73333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-5166,GRADE:3,COHORT:3,PATIENT_ID:MB-5166,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.04,NPI:4.036,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:212.2,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-5163,GRADE:3,COHORT:3,PATIENT_ID:MB-5163,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:65.44,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-5188,GRADE:3,COHORT:3,PATIENT_ID:MB-5188,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:78.8,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:127.9333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-5143,GRADE:2,COHORT:3,PATIENT_ID:MB-5143,TUMOR_STAGE:1
name:MB-5329
name:MB-5322
name:MB-5310
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:76.96,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:28.06666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-MUC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4000,GRADE:2,COHORT:3,PATIENT_ID:MB-4000,TUMOR_STAGE:1
name:MB-5240
name:MB-5228
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:51.09,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:209.2666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-5117,GRADE:2,COHORT:3,PATIENT_ID:MB-5117,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:53.96,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:112.6333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-5176,GRADE:2,COHORT:3,PATIENT_ID:MB-5176,TUMOR_STAGE:1
HER2_SNP6:NEUT,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,AGE_AT_DIAGNOSIS:74.11,NPI:6.056,THREEGENE:ER+/HER2- High Prolif,CELLULARITY:high,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,HORMONE_THERAPY:YES,LATERALITY:r,INTCLUST:8,name:MB-5215,COHORT:3,ER_IHC:pos,OS_MONTHS:118.7,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED
name:MB-5223
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:68.6,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:246.6,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-5179,GRADE:3,COHORT:3,PATIENT_ID:MB-5179,TUMOR_STAGE:1
name:MB-5330
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:57.14,NPI:3.034,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:213.0333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-5144,GRADE:2,COHORT:3,PATIENT_ID:MB-5144,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:52.98,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:94.03333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-5196,GRADE:2,COHORT:3,PATIENT_ID:MB-5196,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:70.23,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:52.3,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-5200,GRADE:3,COHORT:3,PATIENT_ID:MB-5200,TUMOR_STAGE:1
name:MB-5583
name:MB-5601
name:MB-5632
name:MB-5616
name:MB-5604
name:MB-5589
name:MB-5582
name:MB-5571
name:MB-5596
name:MB-5590
name:MB-5599
name:MB-5629
name:MB-5579
name:MB-5623
name:MB-5654
name:MB-5617
name:MB-5638
name:MB-5635
name:MB-5642
name:MB-5647
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:71.32,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:105.6666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4018,GRADE:2,COHORT:3,PATIENT_ID:MB-4018,TUMOR_STAGE:null
name:MB-5584
name:MB-5626
name:MB-5602
name:MB-5653
name:MB-5576
name:MB-5575
name:MB-5646
name:MB-5634
name:MB-5591
name:MB-5567
name:MB-5651
name:MB-5603
name:MB-5622
name:MB-5597
name:MB-5613
name:MB-5580
name:MB-5645
name:MB-5548
name:MB-5526
name:MB-5531
name:MB-5468
name:MB-5474
name:MB-5514
name:MB-5510
name:MB-5473
name:MB-5484
name:MB-5432
name:MB-5525
name:MB-5562
name:MB-5497
name:MB-5551
name:MB-5300
name:MB-5560
name:MB-5550
name:MB-5520
name:MB-5529
name:MB-5554
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:69.01,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:264.7666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4421,GRADE:2,COHORT:3,PATIENT_ID:MB-4421,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:71.66,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:206.5666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-4408,GRADE:3,COHORT:3,PATIENT_ID:MB-4408,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:43.06,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:15.63333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER-,name:MB-4146,GRADE:3,COHORT:3,PATIENT_ID:MB-4146,TUMOR_STAGE:2
name:MB-5534
name:MB-5521
name:MB-5482
name:MB-5483
name:MB-5532
name:MB-5556
name:MB-5518
name:MB-5486
name:MB-5511
name:MB-5422
name:MB-5535
name:MB-5477
name:MB-5472
name:MB-5540
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:79.76,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:89.33333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-5184,GRADE:2,COHORT:3,PATIENT_ID:MB-5184,TUMOR_STAGE:1
name:MB-5294
name:MB-5565
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:72.73,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:79.16666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-5040,GRADE:3,COHORT:3,PATIENT_ID:MB-5040,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:65.83,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:130.3666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4801,GRADE:3,COHORT:3,PATIENT_ID:MB-4801,TUMOR_STAGE:2
name:MB-5499
name:MB-5459
name:MB-5243
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:56.19,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:217.1,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4120,GRADE:2,COHORT:3,PATIENT_ID:MB-4120,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:55.83,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:49.3,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4966,GRADE:1,COHORT:3,PATIENT_ID:MB-4966,TUMOR_STAGE:2
name:MB-5457
HER2_STATUS:-,HER2_SNP6:UNDEF,AGE_AT_DIAGNOSIS:72.36,NPI:4.044,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:193.1666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4011,GRADE:3,COHORT:3,PATIENT_ID:MB-4011,TUMOR_STAGE:null
name:MB-5478
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:76.88,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:91.63333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4822,GRADE:2,COHORT:3,PATIENT_ID:MB-4822,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:76.17,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:139.3,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-4017,GRADE:3,COHORT:3,PATIENT_ID:MB-4017,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:72.12,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:108.6,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-5018,GRADE:2,COHORT:3,PATIENT_ID:MB-5018,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:83.49,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:173.8333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4791,GRADE:1,COHORT:3,PATIENT_ID:MB-4791,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:72.14,NPI:3.024,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:12,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:211.7333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-5118,GRADE:2,COHORT:3,PATIENT_ID:MB-5118,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:49.77,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:201.7666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-4806,GRADE:2,COHORT:3,PATIENT_ID:MB-4806,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:77.45,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:88.8,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4970,GRADE:2,COHORT:3,PATIENT_ID:MB-4970,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:69.48,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-2964,GRADE:3,COHORT:2,PATIENT_ID:MB-2964,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:53.99,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:227.8333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-2963,GRADE:2,COHORT:2,PATIENT_ID:MB-2963,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:31.02,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:262.1333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-2957,GRADE:3,COHORT:2,PATIENT_ID:MB-2957,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.79,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-2954,GRADE:2,COHORT:2,PATIENT_ID:MB-2954,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:48.93,NPI:2.032,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:266.9333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-2916,GRADE:1,COHORT:2,PATIENT_ID:MB-2916,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:44.88,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:236.9333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-2725,GRADE:1,COHORT:2,PATIENT_ID:MB-2725,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:48.07,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:201.4666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:7,name:MB-2711,GRADE:2,COHORT:2,PATIENT_ID:MB-2711,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.99,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:133.7333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-2730,GRADE:3,COHORT:2,PATIENT_ID:MB-2730,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:62.56,NPI:3.048,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:24,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:73.7,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-2669,GRADE:2,COHORT:2,PATIENT_ID:MB-2669,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.78,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:163.7333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-2705,GRADE:2,COHORT:2,PATIENT_ID:MB-2705,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:28.62,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:neg,OS_MONTHS:51.4,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:9,name:MB-2728,GRADE:3,COHORT:2,PATIENT_ID:MB-2728,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:66.36,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:133.2333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-2708,GRADE:2,COHORT:2,PATIENT_ID:MB-2708,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:49.94,NPI:5.024,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:12,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:274.5,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:6,name:MB-2735,GRADE:3,COHORT:2,PATIENT_ID:MB-2735,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:54.64,NPI:3.044,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:260.7333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-3035,GRADE:2,COHORT:2,PATIENT_ID:MB-3035,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:46.7,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:165.1666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-3064,GRADE:1,COHORT:2,PATIENT_ID:MB-3064,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:65.69,NPI:5.072,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:36,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:44.6,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-3060,GRADE:3,COHORT:2,PATIENT_ID:MB-3060,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:57.17,NPI:3.032,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:259.9666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-3049,GRADE:2,COHORT:2,PATIENT_ID:MB-3049,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:53.19,NPI:3.026,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:13,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:98.83333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-3037,GRADE:2,COHORT:2,PATIENT_ID:MB-3037,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:43.51,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:28.56666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-3063,GRADE:3,COHORT:2,PATIENT_ID:MB-3063,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:68.5,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:81.1,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-3083,GRADE:3,COHORT:2,PATIENT_ID:MB-3083,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:67.2,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:73.83333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-3046,GRADE:3,COHORT:2,PATIENT_ID:MB-3046,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:60.29,NPI:5.036,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:259.5333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-MED,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-3067,GRADE:3,COHORT:2,PATIENT_ID:MB-3067,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:39.4,NPI:3.034,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:241.8666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-3351,GRADE:2,COHORT:2,PATIENT_ID:MB-3351,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:65.62,NPI:4.046,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:179.4333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-MED,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-3367,GRADE:3,COHORT:2,PATIENT_ID:MB-3367,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:57.31,NPI:4.032,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:68.2,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-3361,GRADE:3,COHORT:2,PATIENT_ID:MB-3361,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:55.28,NPI:6.052,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:228.8,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-3412,GRADE:3,COHORT:2,PATIENT_ID:MB-3412,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:66.15,NPI:3.032,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:241.2666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-3371,GRADE:2,COHORT:2,PATIENT_ID:MB-3371,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:49.08,NPI:4.052,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:243.5,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-3429,GRADE:2,COHORT:2,PATIENT_ID:MB-3429,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:48.48,NPI:4.056,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:28,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:26.76666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-3360,GRADE:3,COHORT:2,PATIENT_ID:MB-3360,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:50.92,NPI:4.034,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:138.3333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-3403,GRADE:2,COHORT:2,PATIENT_ID:MB-3403,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:62.62,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:227.8,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-3350,GRADE:2,COHORT:2,PATIENT_ID:MB-3350,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:48.53,NPI:6.054,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:27,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:109.0,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-3355,GRADE:3,COHORT:2,PATIENT_ID:MB-3355,TUMOR_STAGE:3
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:56.03,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:37.96666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-3329,GRADE:3,COHORT:2,PATIENT_ID:MB-3329,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:21.93,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:38.8,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-3467,GRADE:2,COHORT:2,PATIENT_ID:MB-3467,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:62.96,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:148.7666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-3341,GRADE:2,COHORT:2,PATIENT_ID:MB-3341,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:48.75,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:242.5666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-3298,GRADE:2,COHORT:2,PATIENT_ID:MB-3298,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:47.75,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:38.03333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:9,name:MB-3357,GRADE:3,COHORT:2,PATIENT_ID:MB-3357,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:59.3,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:228.6,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-3388,GRADE:3,COHORT:2,PATIENT_ID:MB-3388,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:51.18,NPI:4.054,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:27,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:241.6,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-3365,GRADE:2,COHORT:2,PATIENT_ID:MB-3365,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:60.13,NPI:2.026,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:13,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:97.76666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-2749,GRADE:1,COHORT:2,PATIENT_ID:MB-2749,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:66.11,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:203.5333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-2754,GRADE:2,COHORT:2,PATIENT_ID:MB-2754,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:51.36,CELLULARITY:moderate,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:81.93333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-2752,GRADE:2,COHORT:2,PATIENT_ID:MB-2752,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:46.85,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:168.9666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-2745,GRADE:2,COHORT:2,PATIENT_ID:MB-2745,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:68.23,NPI:2.038,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:19,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:234.3333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-2747,GRADE:1,COHORT:2,PATIENT_ID:MB-2747,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.1,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:118.0333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-2760,GRADE:2,COHORT:2,PATIENT_ID:MB-2760,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:48.25,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-2742,GRADE:3,COHORT:2,PATIENT_ID:MB-2742,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:47.48,CELLULARITY:moderate,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:145.4333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-2750,GRADE:1,COHORT:2,PATIENT_ID:MB-2750,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:30.95,NPI:5.074,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:37,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:274.4,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-2753,GRADE:3,COHORT:2,PATIENT_ID:MB-2753,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:50.3,NPI:5.036,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:265.0,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-2966,GRADE:3,COHORT:2,PATIENT_ID:MB-2966,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:43.08,NPI:3.036,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:30.13333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-2953,GRADE:2,COHORT:2,PATIENT_ID:MB-2953,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:66.86,NPI:3.026,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:13,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:172.9,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-2969,GRADE:2,COHORT:2,PATIENT_ID:MB-2969,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:39.7,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:262.6333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:1,name:MB-3014,GRADE:3,COHORT:2,PATIENT_ID:MB-3014,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:36.47,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:112.0,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-2947,GRADE:2,COHORT:2,PATIENT_ID:MB-2947,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:39.07,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:263.3666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:1,name:MB-2951,GRADE:2,COHORT:2,PATIENT_ID:MB-2951,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.67,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:222.2,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-2960,GRADE:3,COHORT:2,PATIENT_ID:MB-2960,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:46.49,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:252.8666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-2970,GRADE:2,COHORT:2,PATIENT_ID:MB-2970,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.6,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:264.2333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-2971,GRADE:2,COHORT:2,PATIENT_ID:MB-2971,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:44.08,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:161.9333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-2933,GRADE:1,COHORT:2,PATIENT_ID:MB-2933,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:60.3,NPI:5.044,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:231.6666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-3479,GRADE:3,COHORT:2,PATIENT_ID:MB-3479,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:45.74,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:102.4,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-3490,GRADE:2,COHORT:2,PATIENT_ID:MB-3490,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:43.58,NPI:4.054,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:27,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:237.1333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:1,name:MB-3487,GRADE:3,COHORT:2,PATIENT_ID:MB-3487,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:57.66,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:241.4,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-3459,GRADE:2,COHORT:2,PATIENT_ID:MB-3459,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:68.59,NPI:4.034,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:159.0666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-MED,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-3476,GRADE:3,COHORT:2,PATIENT_ID:MB-3476,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:62.09,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:118.1333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-3492,GRADE:3,COHORT:2,PATIENT_ID:MB-3492,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:64.04,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:119.8666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-3452,GRADE:3,COHORT:2,PATIENT_ID:MB-3452,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.96,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:243.9,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:OTHER,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-3303,GRADE:3,COHORT:2,PATIENT_ID:MB-3303,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.65,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:191.1333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-3328,GRADE:2,COHORT:2,PATIENT_ID:MB-3328,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:64.99,NPI:3.038,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:19,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:247.0,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-3300,GRADE:2,COHORT:2,PATIENT_ID:MB-3300,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:29.92,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:32.93333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:1,name:MB-3277,GRADE:3,COHORT:2,PATIENT_ID:MB-3277,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:50.21,NPI:2.036,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:123.9,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-3254,GRADE:1,COHORT:2,PATIENT_ID:MB-3254,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:45.0,NPI:4.056,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:28,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:41.53333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:1,name:MB-3275,GRADE:3,COHORT:2,PATIENT_ID:MB-3275,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:63.53,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:22.66666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-3272,GRADE:3,COHORT:2,PATIENT_ID:MB-3272,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:59.43,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:65.46666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-3271,GRADE:3,COHORT:2,PATIENT_ID:MB-3271,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:60.04,NPI:4.036,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:217.7666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-MED,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-3292,GRADE:3,COHORT:2,PATIENT_ID:MB-3292,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:53.89,NPI:3.032,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:287.2333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-3840,GRADE:2,COHORT:2,PATIENT_ID:MB-3840,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:54.11,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:47.9,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-2536,GRADE:1,COHORT:2,PATIENT_ID:MB-2536,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:52.98,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:285.4333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-2564,GRADE:1,COHORT:2,PATIENT_ID:MB-2564,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:57.96,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:59.7,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-2513,GRADE:2,COHORT:2,PATIENT_ID:MB-2513,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.3,NPI:4.036,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:89.1,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-2617,GRADE:3,COHORT:2,PATIENT_ID:MB-2617,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:43.72,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:neg,OS_MONTHS:64.93333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:7,name:MB-2614,GRADE:1,COHORT:2,PATIENT_ID:MB-2614,TUMOR_STAGE:3
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:36.52,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-2632,GRADE:3,COHORT:2,PATIENT_ID:MB-2632,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:62.59,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:220.9,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-2556,GRADE:2,COHORT:2,PATIENT_ID:MB-2556,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:53.53,NPI:3.028,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:14,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:128.5333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-2624,GRADE:1,COHORT:2,PATIENT_ID:MB-2624,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:47.1,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:269.3333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-2867,GRADE:1,COHORT:2,PATIENT_ID:MB-2867,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:45.74,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:1,name:MB-2922,GRADE:3,COHORT:2,PATIENT_ID:MB-2922,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:33.9,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:31.93333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-2917,GRADE:3,COHORT:2,PATIENT_ID:MB-2917,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.94,NPI:4.052,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:141.5666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:MIXED NST AND A SPECIAL TYPE,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-2858,GRADE:3,COHORT:2,PATIENT_ID:MB-2858,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.53,NPI:3.044,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:270.4333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-2854,GRADE:2,COHORT:2,PATIENT_ID:MB-2854,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:36.25,NPI:3.046,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:269.6333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-MUC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:6,name:MB-2853,GRADE:2,COHORT:2,PATIENT_ID:MB-2853,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:50.66,NPI:4.034,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:236.1333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-3235,GRADE:3,COHORT:2,PATIENT_ID:MB-3235,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:59.78,NPI:5.056,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:28,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:221.2333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-3165,GRADE:3,COHORT:2,PATIENT_ID:MB-3165,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:54.95,NPI:3.026,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:13,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:219.6666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-3171,GRADE:2,COHORT:2,PATIENT_ID:MB-3171,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:66.76,NPI:4.032,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:136.9333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-3167,GRADE:2,COHORT:2,PATIENT_ID:MB-3167,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.03,NPI:2.034,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:neg,OS_MONTHS:23.93333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-3222,GRADE:1,COHORT:2,PATIENT_ID:MB-3222,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:55.71,NPI:4.036,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:38.8,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-3706,GRADE:3,COHORT:2,PATIENT_ID:MB-3706,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:53.5,NPI:6.062,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:31,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-3497,GRADE:3,COHORT:2,PATIENT_ID:MB-3497,TUMOR_STAGE:3
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:41.1,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:27.46666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-3488,GRADE:3,COHORT:2,PATIENT_ID:MB-3488,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:41.52,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:222.1,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-3711,GRADE:1,COHORT:2,PATIENT_ID:MB-3711,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:66.85,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:234.5333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-3548,GRADE:2,COHORT:2,PATIENT_ID:MB-3548,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:39.28,NPI:5.032,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:240.8333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:OTHER,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:1,name:MB-3506,GRADE:3,COHORT:2,PATIENT_ID:MB-3506,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:65.56,NPI:6.054,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:27,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:236.7,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-3525,GRADE:3,COHORT:2,PATIENT_ID:MB-3525,TUMOR_STAGE:3
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:68.61,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:110.6333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-3606,GRADE:3,COHORT:2,PATIENT_ID:MB-3606,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:51.36,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:32.83333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-3453,GRADE:3,COHORT:2,PATIENT_ID:MB-3453,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:49.84,NPI:4.042,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:232.7333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:7,name:MB-3545,GRADE:3,COHORT:2,PATIENT_ID:MB-3545,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:56.4,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:null,TUMOR_SIZE:55,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:62.53333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-3470,GRADE:3,COHORT:2,PATIENT_ID:MB-3470,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:65.79,NPI:4.034,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:227.8666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-2765,GRADE:3,COHORT:2,PATIENT_ID:MB-2765,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:70.32,NPI:3.052,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:275.6,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:MIXED NST AND A SPECIAL TYPE,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-2763,GRADE:2,COHORT:2,PATIENT_ID:MB-2763,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:53.11,NPI:5.042,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:271.3333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-2767,GRADE:3,COHORT:2,PATIENT_ID:MB-2767,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:47.03,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:116.9333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-2790,GRADE:2,COHORT:2,PATIENT_ID:MB-2790,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:59.9,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:160.0,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-2769,GRADE:2,COHORT:2,PATIENT_ID:MB-2769,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:58.48,NPI:5.054,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:27,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:19.73333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-2842,GRADE:3,COHORT:2,PATIENT_ID:MB-2842,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:54.4,NPI:4.034,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:150.7333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-2772,GRADE:3,COHORT:2,PATIENT_ID:MB-2772,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:36.8,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:275.2333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-2779,GRADE:2,COHORT:2,PATIENT_ID:MB-2779,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:66.06,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:131.6666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-2774,GRADE:2,COHORT:2,PATIENT_ID:MB-2774,TUMOR_STAGE:3
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:56.26,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:180.8333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-2983,GRADE:2,COHORT:2,PATIENT_ID:MB-2983,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:45.75,NPI:3.046,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:253.0666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-3005,GRADE:2,COHORT:2,PATIENT_ID:MB-3005,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:40.02,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:110.6,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:7,name:MB-2977,GRADE:1,COHORT:2,PATIENT_ID:MB-2977,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:58.1,NPI:4.032,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:191.2333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-2996,GRADE:3,COHORT:2,PATIENT_ID:MB-2996,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.42,NPI:4.024,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:12,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:262.0,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-2999,GRADE:3,COHORT:2,PATIENT_ID:MB-2999,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:46.7,NPI:5.036,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:254.5,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-2994,GRADE:3,COHORT:2,PATIENT_ID:MB-2994,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:37.89,NPI:5.026,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:13,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:256.0,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-3025,GRADE:3,COHORT:2,PATIENT_ID:MB-3025,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:64.04,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:261.2,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-2984,GRADE:3,COHORT:2,PATIENT_ID:MB-2984,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:62.32,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:140.5666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-3002,GRADE:2,COHORT:2,PATIENT_ID:MB-3002,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:55.8,NPI:3.028,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:14,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:264.7666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-2845,GRADE:2,COHORT:2,PATIENT_ID:MB-2845,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:59.6,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:267.4,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-2912,GRADE:3,COHORT:2,PATIENT_ID:MB-2912,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:60.76,NPI:4.038,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:19,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:146.7333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-2844,GRADE:3,COHORT:2,PATIENT_ID:MB-2844,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:65.04,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:39.53333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-2847,GRADE:3,COHORT:2,PATIENT_ID:MB-2847,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:60.65,NPI:4.052,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:43.2,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-2849,GRADE:3,COHORT:2,PATIENT_ID:MB-2849,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:58.69,NPI:4.032,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:159.0,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-2851,GRADE:3,COHORT:2,PATIENT_ID:MB-2851,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:60.11,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:227.7333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-2848,GRADE:2,COHORT:2,PATIENT_ID:MB-2848,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:59.58,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:258.3333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:MIXED NST AND A SPECIAL TYPE,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-2863,GRADE:1,COHORT:2,PATIENT_ID:MB-2863,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:60.48,NPI:3.028,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:14,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:269.0,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-2840,GRADE:2,COHORT:2,PATIENT_ID:MB-2840,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.08,NPI:3.026,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:13,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:231.5333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-2843,GRADE:2,COHORT:2,PATIENT_ID:MB-2843,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:50.37,NPI:3.046,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:238.3666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-3013,GRADE:1,COHORT:2,PATIENT_ID:MB-3013,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:47.74,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:254.2666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER-,name:MB-3058,GRADE:3,COHORT:2,PATIENT_ID:MB-3058,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:56.83,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:258.8666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-3016,GRADE:3,COHORT:2,PATIENT_ID:MB-3016,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:55.3,NPI:5.086,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:43,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:32.03333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-3057,GRADE:3,COHORT:2,PATIENT_ID:MB-3057,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:51.94,NPI:2.024,CELLULARITY:moderate,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:12,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:149.6,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-3008,GRADE:1,COHORT:2,PATIENT_ID:MB-3008,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.08,NPI:5.044,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:217.5666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-3021,GRADE:3,COHORT:2,PATIENT_ID:MB-3021,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:50.01,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:250.1333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-3032,GRADE:1,COHORT:2,PATIENT_ID:MB-3032,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:48.48,NPI:3.024,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:12,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:114.9,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:2,name:MB-3007,GRADE:2,COHORT:2,PATIENT_ID:MB-3007,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.07,NPI:3.038,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:19,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:70.4,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-3033,GRADE:2,COHORT:2,PATIENT_ID:MB-3033,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:49.92,NPI:4.044,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:261.2,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:6,name:MB-3026,GRADE:3,COHORT:2,PATIENT_ID:MB-3026,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:60.09,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-3006,GRADE:2,COHORT:2,PATIENT_ID:MB-3006,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:43.67,NPI:4.034,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:188.7333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-3439,GRADE:2,COHORT:2,PATIENT_ID:MB-3439,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:70.52,NPI:4.042,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:108.7666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-3437,GRADE:3,COHORT:2,PATIENT_ID:MB-3437,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:52.45,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:243.7666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-3395,GRADE:3,COHORT:2,PATIENT_ID:MB-3395,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:40.06,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:55.63333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:1,name:MB-3386,GRADE:3,COHORT:2,PATIENT_ID:MB-3386,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:61.26,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:null,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:136.2333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-3382,GRADE:3,COHORT:2,PATIENT_ID:MB-3382,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:60.99,CELLULARITY:moderate,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:113.8333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-3379,GRADE:3,COHORT:2,PATIENT_ID:MB-3379,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:68.86,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:219.7666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-3430,GRADE:3,COHORT:2,PATIENT_ID:MB-3430,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:63.34,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:240.7,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-3389,GRADE:3,COHORT:2,PATIENT_ID:MB-3389,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:65.5,NPI:3.036,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:87.53333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-3378,GRADE:2,COHORT:2,PATIENT_ID:MB-3378,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.07,NPI:4.032,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:100.7333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-3110,GRADE:2,COHORT:2,PATIENT_ID:MB-3110,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:50.54,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:149.6,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-3079,GRADE:2,COHORT:2,PATIENT_ID:MB-3079,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:58.55,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:28.73333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-3103,GRADE:3,COHORT:2,PATIENT_ID:MB-3103,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:60.34,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:258.3333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-3102,GRADE:2,COHORT:2,PATIENT_ID:MB-3102,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:43.68,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:210.9666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-3085,GRADE:2,COHORT:2,PATIENT_ID:MB-3085,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:62.39,NPI:4.034,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:257.7666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-3122,GRADE:3,COHORT:2,PATIENT_ID:MB-3122,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:28.96,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:75.36666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-3104,GRADE:2,COHORT:2,PATIENT_ID:MB-3104,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:50.26,NPI:6.044,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:167.4333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-3123,GRADE:3,COHORT:2,PATIENT_ID:MB-3123,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.06,NPI:2.024,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:12,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:131.3333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-3121,GRADE:1,COHORT:2,PATIENT_ID:MB-3121,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:59.84,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:55.03333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-2835,GRADE:3,COHORT:2,PATIENT_ID:MB-2835,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:67.12,NPI:3.054,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:27,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:270.3,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-2838,GRADE:2,COHORT:2,PATIENT_ID:MB-2838,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:70.35,NPI:4.026,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:13,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:271.2666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-2801,GRADE:2,COHORT:2,PATIENT_ID:MB-2801,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:56.85,NPI:4.018,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:9,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:153.8333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-2834,GRADE:2,COHORT:2,PATIENT_ID:MB-2834,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:57.94,CELLULARITY:moderate,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:null,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:87.7,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-2796,GRADE:3,COHORT:2,PATIENT_ID:MB-2796,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:45.3,NPI:5.044,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:250.6666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-2857,GRADE:3,COHORT:2,PATIENT_ID:MB-2857,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.95,NPI:2.038,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:19,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:270.5666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-2819,GRADE:1,COHORT:2,PATIENT_ID:MB-2819,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:64.32,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:40.43333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-2781,GRADE:2,COHORT:2,PATIENT_ID:MB-2781,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:67.62,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:267.2333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-2793,GRADE:2,COHORT:2,PATIENT_ID:MB-2793,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:36.5,NPI:5.022,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:11,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:235.6666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-2827,GRADE:3,COHORT:2,PATIENT_ID:MB-2827,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:65.25,NPI:3.026,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:13,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:231.0333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-2814,GRADE:2,COHORT:2,PATIENT_ID:MB-2814,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:40.79,NPI:3.034,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:271.9333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-2791,GRADE:2,COHORT:2,PATIENT_ID:MB-2791,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.01,NPI:3.036,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:85.86666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-2803,GRADE:2,COHORT:2,PATIENT_ID:MB-2803,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:50.07,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:252.9666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-2797,GRADE:1,COHORT:2,PATIENT_ID:MB-2797,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:42.07,NPI:3.024,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:12,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:272.1,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:1,name:MB-2795,GRADE:2,COHORT:2,PATIENT_ID:MB-2795,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:62.36,NPI:5.056,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:28,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:68.26666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-2786,GRADE:3,COHORT:2,PATIENT_ID:MB-2786,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:65.89,CELLULARITY:moderate,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:72.3,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-3850,GRADE:2,COHORT:2,PATIENT_ID:MB-3850,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:51.76,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:80,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:38.03333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-3556,GRADE:3,COHORT:2,PATIENT_ID:MB-3556,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:60.45,NPI:4.046,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:134.4666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-3838,GRADE:3,COHORT:2,PATIENT_ID:MB-3838,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:70.77,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:228.7666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-3707,GRADE:3,COHORT:2,PATIENT_ID:MB-3707,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:60.15,NPI:4.024,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:12,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:214.7,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-3600,GRADE:2,COHORT:2,PATIENT_ID:MB-3600,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:49.45,NPI:4.044,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:126.4666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:2,name:MB-3824,GRADE:3,COHORT:2,PATIENT_ID:MB-3824,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:48.16,NPI:3.036,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:224.5666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-3781,GRADE:2,COHORT:2,PATIENT_ID:MB-3781,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:30.67,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:neg,OS_MONTHS:45.16666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:1,name:MB-2642,GRADE:3,COHORT:2,PATIENT_ID:MB-2642,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:68.76,NPI:5.034,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:177.2666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-2686,GRADE:3,COHORT:2,PATIENT_ID:MB-2686,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:65.07,NPI:3.036,CELLULARITY:moderate,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:219.1666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-2616,GRADE:2,COHORT:2,PATIENT_ID:MB-2616,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:70.69,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:274.0333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-2634,GRADE:3,COHORT:2,PATIENT_ID:MB-2634,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:59.63,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:163.4,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-2613,GRADE:3,COHORT:2,PATIENT_ID:MB-2613,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:54.6,NPI:5.048,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:24,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:226.0666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-3842,GRADE:3,COHORT:2,PATIENT_ID:MB-3842,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:54.29,NPI:4.024,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:12,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:225.5,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-3866,GRADE:3,COHORT:2,PATIENT_ID:MB-3866,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:35.5,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:186.4333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:7,name:MB-3874,GRADE:2,COHORT:2,PATIENT_ID:MB-3874,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:62.03,NPI:4.052,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:172.8,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-3871,GRADE:2,COHORT:2,PATIENT_ID:MB-3871,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:37.16,NPI:5.011,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:5.May,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:230.4666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-3702,GRADE:3,COHORT:2,PATIENT_ID:MB-3702,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:48.34,NPI:3.054,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:27,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:252.3333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-3105,GRADE:1,COHORT:2,PATIENT_ID:MB-3105,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:43.56,NPI:4.046,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:225.5,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-3852,GRADE:3,COHORT:2,PATIENT_ID:MB-3852,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.82,NPI:2.024,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:12,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:neg,OS_MONTHS:99.23333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-3854,GRADE:1,COHORT:2,PATIENT_ID:MB-3854,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:49.37,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:199.9666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-3865,GRADE:1,COHORT:2,PATIENT_ID:MB-3865,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:58.31,NPI:3.034,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:252.0,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-3228,GRADE:2,COHORT:2,PATIENT_ID:MB-3228,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:60.93,NPI:4.034,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:null,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:42.56666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-3028,GRADE:3,COHORT:2,PATIENT_ID:MB-3028,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:50.79,NPI:5.054,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:27,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:229.3333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-3502,GRADE:3,COHORT:2,PATIENT_ID:MB-3502,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:55.95,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:236.0333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-3567,GRADE:3,COHORT:2,PATIENT_ID:MB-3567,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:49.98,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:75.33333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-MED,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER-,name:MB-3752,GRADE:3,COHORT:2,PATIENT_ID:MB-3752,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:51.52,NPI:3.034,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:240.4666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-3450,GRADE:2,COHORT:2,PATIENT_ID:MB-3450,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:49.87,NPI:5.066,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:33,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:55.46666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-0444,GRADE:2,COHORT:1,PATIENT_ID:MB-0444,TUMOR_STAGE:4
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:54.62,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:130.4333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-0476,GRADE:3,COHORT:1,PATIENT_ID:MB-0476,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:71.3,NPI:4.036,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:76.7,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0610,GRADE:2,COHORT:1,PATIENT_ID:MB-0610,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.2,NPI:2.032,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:50.06666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0451,GRADE:1,COHORT:1,PATIENT_ID:MB-0451,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:58.89,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:80,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:151.0,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0133,GRADE:1,COHORT:1,PATIENT_ID:MB-0133,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:48.87,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:163.1,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-0005,GRADE:2,COHORT:1,PATIENT_ID:MB-0005,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:51.46,CELLULARITY:low,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:103.8333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0048,GRADE:2,COHORT:1,PATIENT_ID:MB-0048,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:64.85,NPI:3.026,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:13,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:86.06666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-0083,GRADE:2,COHORT:1,PATIENT_ID:MB-0083,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:70.02,NPI:3.046,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:161.0666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0053,GRADE:2,COHORT:1,PATIENT_ID:MB-0053,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:62.62,NPI:3.058,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:29,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:62.86666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-0056,GRADE:2,COHORT:1,PATIENT_ID:MB-0056,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:51.01,NPI:3.024,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:12,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:103.1333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0068,GRADE:1,COHORT:1,PATIENT_ID:MB-0068,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:43.55,NPI:5.028,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:14,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:153.2,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-0093,GRADE:3,COHORT:1,PATIENT_ID:MB-0093,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:50.42,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0079,GRADE:3,COHORT:1,PATIENT_ID:MB-0079,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:43.15,NPI:4.036,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:42.7,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-0108,GRADE:3,COHORT:1,PATIENT_ID:MB-0108,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:47.68,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:164.9333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:9,name:MB-0006,GRADE:2,COHORT:1,PATIENT_ID:MB-0006,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:56.45,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:164.3333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0014,GRADE:2,COHORT:1,PATIENT_ID:MB-0014,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:89.08,NPI:4.058,CELLULARITY:moderate,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:29,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:99.53333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0022,GRADE:2,COHORT:1,PATIENT_ID:MB-0022,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:70.91,NPI:2.042,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:163.5333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:OTHER INVASIVE,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0039,GRADE:1,COHORT:1,PATIENT_ID:MB-0039,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:52.14,NPI:4.034,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:153.9666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-MED,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0062,GRADE:3,COHORT:1,PATIENT_ID:MB-0062,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:66.91,NPI:4.072,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:36,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:160.3,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0054,GRADE:3,COHORT:1,PATIENT_ID:MB-0054,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:49.61,NPI:3.048,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:24,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:69.5,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-0081,GRADE:2,COHORT:1,PATIENT_ID:MB-0081,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:69.13,NPI:3.036,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:108.9333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0064,GRADE:2,COHORT:1,PATIENT_ID:MB-0064,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:65.59,NPI:4.036,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:158.0333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-0107,GRADE:3,COHORT:1,PATIENT_ID:MB-0107,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:60.66,NPI:1.034,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:251.8,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4681,GRADE:null,COHORT:3,PATIENT_ID:MB-4681,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:64.61,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:143.0,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-4626,GRADE:3,COHORT:3,PATIENT_ID:MB-4626,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:71.17,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:119.0,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-4639,GRADE:3,COHORT:3,PATIENT_ID:MB-4639,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:63.27,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:87.0,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-4673,GRADE:2,COHORT:3,PATIENT_ID:MB-4673,TUMOR_STAGE:3
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:56.07,NPI:6.198,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:99,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:31.46666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-4711,GRADE:3,COHORT:3,PATIENT_ID:MB-4711,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:55.42,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:121.7333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4607,GRADE:2,COHORT:3,PATIENT_ID:MB-4607,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:68.82,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:119.4666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-4669,GRADE:3,COHORT:3,PATIENT_ID:MB-4669,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:76.13,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-4015,GRADE:2,COHORT:3,PATIENT_ID:MB-4015,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:46.9,NPI:3.034,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:228.1,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-2931,GRADE:2,COHORT:2,PATIENT_ID:MB-2931,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:58.14,NPI:2.026,CELLULARITY:null,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:13,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:263.7,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-2927,GRADE:1,COHORT:2,PATIENT_ID:MB-2927,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:59.13,CELLULARITY:low,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:240.0333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-MUC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-2919,GRADE:1,COHORT:2,PATIENT_ID:MB-2919,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:66.97,NPI:4.054,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:null,TUMOR_SIZE:27,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:neg,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-2944,GRADE:3,COHORT:2,PATIENT_ID:MB-2944,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:53.31,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:262.8666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-2929,GRADE:2,COHORT:2,PATIENT_ID:MB-2929,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.1,NPI:4.036,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:108.4333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-2932,GRADE:3,COHORT:2,PATIENT_ID:MB-2932,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:60.59,NPI:4.016,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:8,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:108.0666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-2724,GRADE:3,COHORT:2,PATIENT_ID:MB-2724,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:54.59,NPI:3.022,CELLULARITY:null,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:11,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:234.4333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-2712,GRADE:1,COHORT:2,PATIENT_ID:MB-2712,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:62.87,NPI:4.034,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:146.3666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-3062,GRADE:3,COHORT:2,PATIENT_ID:MB-3062,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:59.53,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:255.1,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-3050,GRADE:3,COHORT:2,PATIENT_ID:MB-3050,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:64.02,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:NA,OS_MONTHS:86.1,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4722,GRADE:null,COHORT:3,PATIENT_ID:MB-4722,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:49.43,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:60,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:44.86666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-4731,GRADE:3,COHORT:3,PATIENT_ID:MB-4731,TUMOR_STAGE:null
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:65.83,NPI:5.052,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:98.76666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-4725,GRADE:3,COHORT:3,PATIENT_ID:MB-4725,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:59.85,NPI:4.054,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:27,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:221.2,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-4707,GRADE:3,COHORT:3,PATIENT_ID:MB-4707,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:78.21,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:41.46666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-4643,GRADE:3,COHORT:3,PATIENT_ID:MB-4643,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:56.42,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:10.86666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-3363,GRADE:3,COHORT:2,PATIENT_ID:MB-3363,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:38.49,NPI:6.056,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:28,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-3383,GRADE:3,COHORT:2,PATIENT_ID:MB-3383,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:33.76,NPI:3.046,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:241.2666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-3344,GRADE:2,COHORT:2,PATIENT_ID:MB-3344,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:53.36,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:236.6333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-3381,GRADE:3,COHORT:2,PATIENT_ID:MB-3381,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:42.72,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:236.0666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-3297,GRADE:3,COHORT:2,PATIENT_ID:MB-3297,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:49.5,NPI:3.064,CELLULARITY:null,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:32,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:248.7666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-3301,GRADE:2,COHORT:2,PATIENT_ID:MB-3301,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:65.58,NPI:3.038,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:19,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:256.5,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-3088,GRADE:2,COHORT:2,PATIENT_ID:MB-3088,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:57.48,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:null,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:270.1333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-2764,GRADE:2,COHORT:2,PATIENT_ID:MB-2764,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:45.57,CELLULARITY:null,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:275.6333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-2744,GRADE:2,COHORT:2,PATIENT_ID:MB-2744,TUMOR_STAGE:1
name:MB-7114
name:MB-7118
name:MB-7113
name:MB-7130
name:MB-7149
name:MB-7140
name:MB-7208
name:MB-7170
name:MB-7174
name:MB-7252
name:MB-7244
name:MB-7187
name:MB-7251
name:MB-7173
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:50.45,NPI:5.024,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:12,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:263.2333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-3001,GRADE:3,COHORT:2,PATIENT_ID:MB-3001,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:52.67,NPI:2.024,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:12,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:189.1,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-2952,GRADE:1,COHORT:2,PATIENT_ID:MB-2952,TUMOR_STAGE:1
name:MB-7097
name:MB-7104
name:MB-7099
name:MB-7069
name:MB-7066
name:MB-7100
name:MB-7067
name:MB-7073
name:MB-7063
name:MB-7102
name:MB-7068
name:MB-7075
name:MB-7053
name:MB-7074
name:MB-7057
name:MB-7109
name:MB-7051
name:MB-7071
name:MB-7106
name:MB-7059
name:MB-7107
name:MB-7076
name:MB-7111
name:MB-7015
name:MB-7026
name:MB-7013
name:MB-7023
name:MB-7024
name:MB-7014
name:MB-7017
name:MB-7019
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:67.6,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:59.6,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-3510,GRADE:1,COHORT:2,PATIENT_ID:MB-3510,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:66.91,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:239.3,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-3500,GRADE:3,COHORT:2,PATIENT_ID:MB-3500,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:59.29,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:226.7333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-3396,GRADE:3,COHORT:2,PATIENT_ID:MB-3396,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:37.05,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:25.43333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-3435,GRADE:3,COHORT:2,PATIENT_ID:MB-3435,TUMOR_STAGE:2
name:MB-7186
name:MB-7142
name:MB-7196
name:MB-7171
name:MB-7145
name:MB-7132
name:MB-7189
name:MB-7137
name:MB-7181
name:MB-7155
name:MB-7138
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:60.42,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:158.5333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-3295,GRADE:3,COHORT:2,PATIENT_ID:MB-3295,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:44.94,NPI:5.034,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:248.7666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-3218,GRADE:3,COHORT:2,PATIENT_ID:MB-3218,TUMOR_STAGE:2
name:MB-7232
name:MB-7281
name:MB-7270
name:MB-7231
name:MB-7220
name:MB-7277
name:MB-7269
name:MB-7280
name:MB-7227
name:MB-7278
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:58.99,CELLULARITY:low,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:280.7,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-2610,GRADE:1,COHORT:2,PATIENT_ID:MB-2610,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:60.29,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:268.4333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-2517,GRADE:3,COHORT:2,PATIENT_ID:MB-2517,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:68.18,NPI:3.026,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:13,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:237.3666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-2896,GRADE:2,COHORT:2,PATIENT_ID:MB-2896,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:49.83,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:218.3,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-2901,GRADE:2,COHORT:2,PATIENT_ID:MB-2901,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:66.84,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:196.5666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-2895,GRADE:3,COHORT:2,PATIENT_ID:MB-2895,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:59.29,CELLULARITY:low,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:20.66666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-2900,GRADE:2,COHORT:2,PATIENT_ID:MB-2900,TUMOR_STAGE:3
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:70.19,NPI:5.034,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:101.2666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-2939,GRADE:3,COHORT:2,PATIENT_ID:MB-2939,TUMOR_STAGE:2
name:MB-7008
name:MB-7002
name:MB-7000
name:MB-7006
name:MB-7007
name:MB-7011
name:MB-7001
name:MB-7009
name:MB-7003
name:MB-7005
name:MB-7010
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:42.17,NPI:5.032,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:227.9333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-3153,GRADE:3,COHORT:2,PATIENT_ID:MB-3153,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:58.31,NPI:4.026,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:13,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:145.5,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-3211,GRADE:3,COHORT:2,PATIENT_ID:MB-3211,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:43.6,NPI:4.028,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:14,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:178.1666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:2,name:MB-3181,GRADE:3,COHORT:2,PATIENT_ID:MB-3181,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:41.4,CELLULARITY:null,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:99.7,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-MUC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-3252,GRADE:1,COHORT:2,PATIENT_ID:MB-3252,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:52.91,NPI:5.034,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:51.2,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-3266,GRADE:3,COHORT:2,PATIENT_ID:MB-3266,TUMOR_STAGE:2
name:MB-7082
name:MB-7081
name:MB-7093
name:MB-7083
name:MB-7091
name:MB-7065
name:MB-7085
name:MB-7096
name:MB-7018
name:MB-7088
name:MB-7055
name:MB-7080
name:MB-7161
name:MB-7115
name:MB-7123
name:MB-7176
name:MB-7121
name:MB-7172
name:MB-7164
name:MB-7127
name:MB-7128
name:MB-7157
name:MB-7092
name:MB-7135
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:57.01,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:92.73333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-3754,GRADE:3,COHORT:2,PATIENT_ID:MB-3754,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:UNDEF,AGE_AT_DIAGNOSIS:48.12,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:86.23333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-3536,GRADE:2,COHORT:2,PATIENT_ID:MB-3536,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:51.01,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:228.0,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-3748,GRADE:3,COHORT:2,PATIENT_ID:MB-3748,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:70.94,NPI:4.052,CELLULARITY:null,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:112.9666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-3530,GRADE:2,COHORT:2,PATIENT_ID:MB-3530,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.97,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:60,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:neg,OS_MONTHS:229.3666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:null,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-3582,GRADE:null,COHORT:2,PATIENT_ID:MB-3582,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:71.03,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:113.6666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-3528,GRADE:3,COHORT:2,PATIENT_ID:MB-3528,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:53.04,NPI:4.074,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:37,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:24.86666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-3576,GRADE:3,COHORT:2,PATIENT_ID:MB-3576,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:60.32,CELLULARITY:null,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:45,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:274.3666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-2770,GRADE:2,COHORT:2,PATIENT_ID:MB-2770,TUMOR_STAGE:3
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:38.16,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:45,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:35.0,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER-,name:MB-2758,GRADE:3,COHORT:2,PATIENT_ID:MB-2758,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:56.79,NPI:4.032,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:44.83333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-2771,GRADE:3,COHORT:2,PATIENT_ID:MB-2771,TUMOR_STAGE:1
name:MB-7152
name:MB-7143
name:MB-7197
name:MB-7153
name:MB-7144
name:MB-7185
name:MB-7199
name:MB-7158
name:MB-7163
name:MB-7215
name:MB-7200
name:MB-7193
name:MB-7198
name:MB-7256
name:MB-7258
name:MB-7194
name:MB-7254
name:MB-7262
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:48.47,CELLULARITY:low,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:260.0,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-2990,GRADE:1,COHORT:2,PATIENT_ID:MB-2990,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.65,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:187.0333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-2993,GRADE:3,COHORT:2,PATIENT_ID:MB-2993,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:46.76,NPI:5.042,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:35.63333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-MED,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-3031,GRADE:3,COHORT:2,PATIENT_ID:MB-3031,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:34.83,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:125.6,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-2904,GRADE:3,COHORT:2,PATIENT_ID:MB-2904,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:58.85,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:5,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:149.7,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-2846,GRADE:2,COHORT:2,PATIENT_ID:MB-2846,TUMOR_STAGE:1
name:MB-7154
name:MB-7229
name:MB-7151
name:MB-7228
name:MB-7218
name:MB-7147
name:MB-7219
name:MB-7165
name:MB-7150
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:38.2,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:null,TUMOR_SIZE:130,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:neg,OS_MONTHS:50.76666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:1,name:MB-3436,GRADE:3,COHORT:2,PATIENT_ID:MB-3436,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:40.92,NPI:4.032,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:234.2333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-3462,GRADE:2,COHORT:2,PATIENT_ID:MB-3462,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:59.16,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:103.4666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-3417,GRADE:2,COHORT:2,PATIENT_ID:MB-3417,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:44.82,NPI:2.018,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:9,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:neg,OS_MONTHS:251.6333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:7,name:MB-2721,GRADE:1,COHORT:2,PATIENT_ID:MB-2721,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:56.73,NPI:5.076,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:38,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:152.3333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-3092,GRADE:3,COHORT:2,PATIENT_ID:MB-3092,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:57.39,NPI:1.032,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:neg,OS_MONTHS:136.0666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-MED,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-2821,GRADE:null,COHORT:2,PATIENT_ID:MB-2821,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:31.48,NPI:6.062,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:31,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:9.433333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-2850,GRADE:3,COHORT:2,PATIENT_ID:MB-2850,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:40.06,NPI:4.036,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:254.6333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-2820,GRADE:3,COHORT:2,PATIENT_ID:MB-2820,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:35.97,NPI:4.022,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:11,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:269.9,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-2823,GRADE:3,COHORT:2,PATIENT_ID:MB-2823,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:50.38,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:110.7666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-2792,GRADE:2,COHORT:2,PATIENT_ID:MB-2792,TUMOR_STAGE:2
name:MB-7273
name:MB-7283
name:MB-7284
name:MB-7279
name:MB-7233
name:MB-7287
name:MB-7250
name:MB-7238
name:MB-7285
name:MB-7260
name:MB-7264
name:MB-7268
name:MB-7276
name:MB-7212
name:MB-7267
name:MB-7266
name:MB-7216
name:MB-7195
name:MB-7201
name:MB-7217
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:62.76,NPI:4.034,CELLULARITY:low,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:181.2333333,CLAUDIN_SUBTYPE:NC,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-2778,GRADE:2,COHORT:2,PATIENT_ID:MB-2778,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:64.25,NPI:2.044,CELLULARITY:low,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:257.5666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-2815,GRADE:1,COHORT:2,PATIENT_ID:MB-2815,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:42.9,NPI:5.046,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:259.7666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-2833,GRADE:3,COHORT:2,PATIENT_ID:MB-2833,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.95,NPI:5.068,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:34,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:235.4,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-3614,GRADE:3,COHORT:2,PATIENT_ID:MB-3614,TUMOR_STAGE:2
name:MB-7052
name:MB-7124
name:MB-7122
name:MB-7133
name:MB-7084
name:MB-7101
name:MB-7116
name:MB-7131
name:MB-7090
name:MB-7095
name:MB-7094
name:MB-7087
name:MB-7077
name:MB-7072
name:MB-7041
name:MB-7044
name:MB-7022
name:MB-7070
name:MB-7079
name:MB-7035
name:MB-7025
name:MB-7062
name:MB-7036
name:MB-7046
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:67.26,NPI:1.024,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:12,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:NA,OS_MONTHS:299.4,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4839,GRADE:null,COHORT:3,PATIENT_ID:MB-4839,TUMOR_STAGE:null
name:MB-5559
name:MB-5463
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:64.21,NPI:5.032,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:153.0,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4744,GRADE:3,COHORT:3,PATIENT_ID:MB-4744,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:65.86,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-4769,GRADE:3,COHORT:3,PATIENT_ID:MB-4769,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:66.23,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:55,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:52.3,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4484,GRADE:3,COHORT:3,PATIENT_ID:MB-4484,TUMOR_STAGE:null
name:MB-5558
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:73.21,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:37.73333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4750,GRADE:2,COHORT:3,PATIENT_ID:MB-4750,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:72.49,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:83.36666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-4793,GRADE:3,COHORT:3,PATIENT_ID:MB-4793,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:54.35,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:265.1333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4843,GRADE:null,COHORT:3,PATIENT_ID:MB-4843,TUMOR_STAGE:2
name:MB-5563
name:MB-5513
name:MB-5656
name:MB-5530
name:MB-5553
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:55.66,NPI:4.032,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:23.43333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4836,GRADE:3,COHORT:3,PATIENT_ID:MB-4836,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:78.87,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:80,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:42.5,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-4828,GRADE:3,COHORT:3,PATIENT_ID:MB-4828,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:79.01,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:118.0,CLAUDIN_SUBTYPE:NC,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4697,GRADE:null,COHORT:3,PATIENT_ID:MB-4697,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:64.11,CELLULARITY:low,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:292.6666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-MED,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-4679,GRADE:3,COHORT:3,PATIENT_ID:MB-4679,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:82.17,NPI:5.044,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4033,GRADE:2,COHORT:3,PATIENT_ID:MB-4033,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:58.49,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:107.2666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:OTHER INVASIVE,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4692,GRADE:1,COHORT:3,PATIENT_ID:MB-4692,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:59.23,NPI:4.036,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:263.0333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4675,GRADE:3,COHORT:3,PATIENT_ID:MB-4675,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:44.5,NPI:4.062,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:31,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:48.13333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-4653,GRADE:3,COHORT:3,PATIENT_ID:MB-4653,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:61.97,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:239.3333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-4663,GRADE:3,COHORT:3,PATIENT_ID:MB-4663,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:37.53,NPI:6.056,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:28,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:39.86666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:9,name:MB-4660,GRADE:3,COHORT:3,PATIENT_ID:MB-4660,TUMOR_STAGE:2
name:MB-5275
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:80.82,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:64.3,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4654,GRADE:3,COHORT:3,PATIENT_ID:MB-4654,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:66.22,NPI:3.032,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:89.1,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-2618,GRADE:2,COHORT:2,PATIENT_ID:MB-2618,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:47.94,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:278.2666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-2718,GRADE:2,COHORT:2,PATIENT_ID:MB-2718,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:34.2,NPI:3.006,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:3,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:NA,OS_MONTHS:52.96666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER-,name:MB-2643,GRADE:2,COHORT:2,PATIENT_ID:MB-2643,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.22,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:279.1,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-2629,GRADE:3,COHORT:2,PATIENT_ID:MB-2629,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.45,NPI:6.054,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:27,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:44.76666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-2645,GRADE:3,COHORT:2,PATIENT_ID:MB-2645,TUMOR_STAGE:3
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:62.54,NPI:4.032,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:193.7,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-2626,GRADE:3,COHORT:2,PATIENT_ID:MB-2626,TUMOR_STAGE:1
name:MB-6263
name:MB-6305
name:MB-6185
name:MB-6187
name:MB-6248
name:MB-6330
name:MB-6184
name:MB-6329
name:MB-6283
name:MB-6359
name:MB-6337
name:MB-6256
name:MB-6201
name:MB-6207
name:MB-6194
name:MB-6281
name:MB-6322
name:MB-6223
name:MB-6190
name:MB-6306
name:MB-6188
name:MB-6318
name:MB-6228
name:MB-6226
name:MB-6225
name:MB-6280
name:MB-6253
name:MB-6098
name:MB-6017
name:MB-6019
name:MB-6163
name:MB-6157
name:MB-6179
name:MB-6105
name:MB-6047
name:MB-6001
name:MB-6050
name:MB-6169
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:50.42,NPI:5.002,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:1,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:322.8333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-4548,GRADE:3,COHORT:3,PATIENT_ID:MB-4548,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:74.67,NPI:6.036,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:210.4333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4564,GRADE:3,COHORT:3,PATIENT_ID:MB-4564,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:71.93,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:41.16666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-4591,GRADE:3,COHORT:3,PATIENT_ID:MB-4591,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:51.25,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:279.8,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4557,GRADE:1,COHORT:3,PATIENT_ID:MB-4557,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:39.14,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:56.26666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-4601,GRADE:3,COHORT:3,PATIENT_ID:MB-4601,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:67.92,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:119.3666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4598,GRADE:2,COHORT:3,PATIENT_ID:MB-4598,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:72.74,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:45,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:197.3333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4578,GRADE:2,COHORT:3,PATIENT_ID:MB-4578,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:48.44,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:140.2333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-4593,GRADE:2,COHORT:3,PATIENT_ID:MB-4593,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:42.84,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:203.2666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:6,name:MB-5186,GRADE:null,COHORT:3,PATIENT_ID:MB-5186,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:65.16,NPI:4.036,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:176.1,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-4974,GRADE:3,COHORT:3,PATIENT_ID:MB-4974,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:58.89,CELLULARITY:low,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:198.4333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4978,GRADE:null,COHORT:3,PATIENT_ID:MB-4978,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:65.41,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:84.23333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-5086,GRADE:null,COHORT:3,PATIENT_ID:MB-5086,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.29,NPI:3.002,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:1,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:110.8333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-5150,GRADE:2,COHORT:3,PATIENT_ID:MB-5150,TUMOR_STAGE:1
name:MB-5345
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:49.98,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:45,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:255.2666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-4696,GRADE:3,COHORT:3,PATIENT_ID:MB-4696,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.12,CELLULARITY:low,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4695,GRADE:2,COHORT:3,PATIENT_ID:MB-4695,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:64.68,NPI:6.002,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:1,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:83.66666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-4714,GRADE:3,COHORT:3,PATIENT_ID:MB-4714,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.58,NPI:3.054,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:27,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:213.1,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4705,GRADE:2,COHORT:3,PATIENT_ID:MB-4705,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:76.71,NPI:2.014,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:7,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:NA,OS_MONTHS:266.1,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4882,GRADE:1,COHORT:3,PATIENT_ID:MB-4882,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:49.34,NPI:4.036,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:NA,OS_MONTHS:79.96666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-4879,GRADE:3,COHORT:3,PATIENT_ID:MB-4879,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:37.05,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:274.2,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-4881,GRADE:3,COHORT:3,PATIENT_ID:MB-4881,TUMOR_STAGE:null
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:63.07,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:101.6333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-4846,GRADE:2,COHORT:3,PATIENT_ID:MB-4846,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:57.33,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:229.0666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4870,GRADE:1,COHORT:3,PATIENT_ID:MB-4870,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:72.39,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:65.5,CLAUDIN_SUBTYPE:NC,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4224,GRADE:2,COHORT:3,PATIENT_ID:MB-4224,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:86.75,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:25.46666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4845,GRADE:null,COHORT:3,PATIENT_ID:MB-4845,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:64.3,NPI:5.0,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:null,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:129.2333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:null,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-4904,GRADE:3,COHORT:3,PATIENT_ID:MB-4904,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:50.7,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:229.9,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-4865,GRADE:3,COHORT:3,PATIENT_ID:MB-4865,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:42.45,NPI:3.056,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:28,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:150.6,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-4876,GRADE:2,COHORT:3,PATIENT_ID:MB-4876,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:44.95,CELLULARITY:low,ONCOTREE_CODE:ILC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:234.6,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-4860,GRADE:2,COHORT:3,PATIENT_ID:MB-4860,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:43.63,NPI:3.032,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:58.0,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:9,name:MB-5081,GRADE:2,COHORT:3,PATIENT_ID:MB-5081,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:40.04,NPI:2.002,CELLULARITY:low,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:1,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:197.4333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-4897,GRADE:1,COHORT:3,PATIENT_ID:MB-4897,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:76.54,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:102.7666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4925,GRADE:2,COHORT:3,PATIENT_ID:MB-4925,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:57.93,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:NA,OS_MONTHS:268.9,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4883,GRADE:2,COHORT:3,PATIENT_ID:MB-4883,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:41.53,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:64.86666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-4896,GRADE:3,COHORT:3,PATIENT_ID:MB-4896,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:76.37,CELLULARITY:low,ONCOTREE_CODE:ILC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:221.7666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4987,GRADE:2,COHORT:3,PATIENT_ID:MB-4987,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:44.89,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:241.6,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-MED,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER-,name:MB-4416,GRADE:3,COHORT:3,PATIENT_ID:MB-4416,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:77.51,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:42.56666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4374,GRADE:3,COHORT:3,PATIENT_ID:MB-4374,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:44.4,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:83.36666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-4407,GRADE:3,COHORT:3,PATIENT_ID:MB-4407,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:67.7,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:55,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:62.13333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-5039,GRADE:3,COHORT:3,PATIENT_ID:MB-5039,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:65.46,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:67.8,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4119,GRADE:2,COHORT:3,PATIENT_ID:MB-4119,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:74.45,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:281.3666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4091,GRADE:3,COHORT:3,PATIENT_ID:MB-4091,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:66.38,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:199.9333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-5079,GRADE:2,COHORT:3,PATIENT_ID:MB-5079,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:67.87,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:194.1666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-MED,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-5073,GRADE:null,COHORT:3,PATIENT_ID:MB-5073,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.24,NPI:3.022,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:11,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:204.4333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-5105,GRADE:2,COHORT:3,PATIENT_ID:MB-5105,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:68.7,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:178.4,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-MED,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-4254,GRADE:3,COHORT:3,PATIENT_ID:MB-4254,TUMOR_STAGE:null
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:54.69,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:NA,OS_MONTHS:151.2,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-5174,GRADE:null,COHORT:3,PATIENT_ID:MB-5174,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:76.42,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:83.13333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4742,GRADE:null,COHORT:3,PATIENT_ID:MB-4742,TUMOR_STAGE:2
name:MB-5239
name:MB-5251
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.65,NPI:3.036,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:99.76666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4996,GRADE:1,COHORT:3,PATIENT_ID:MB-4996,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:49.61,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:34.1,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:9,name:MB-4282,GRADE:3,COHORT:3,PATIENT_ID:MB-4282,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:42.79,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:239.2333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-4603,GRADE:2,COHORT:3,PATIENT_ID:MB-4603,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:39.51,NPI:6.106,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:53,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:271.8666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-4621,GRADE:3,COHORT:3,PATIENT_ID:MB-4621,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:62.35,NPI:3.032,CELLULARITY:moderate,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:265.9333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4853,GRADE:null,COHORT:3,PATIENT_ID:MB-4853,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:50.08,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:267.2666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4362,GRADE:3,COHORT:3,PATIENT_ID:MB-4362,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:58.38,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:122.8,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-4602,GRADE:3,COHORT:3,PATIENT_ID:MB-4602,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:58.8,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:55.23333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4222,GRADE:1,COHORT:3,PATIENT_ID:MB-4222,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:33.04,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:176.7,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-4893,GRADE:3,COHORT:3,PATIENT_ID:MB-4893,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:74.29,NPI:3.034,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:157.8,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4859,GRADE:2,COHORT:3,PATIENT_ID:MB-4859,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:45.5,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:330.3666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-4212,GRADE:2,COHORT:3,PATIENT_ID:MB-4212,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:64.47,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:117.6666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4873,GRADE:2,COHORT:3,PATIENT_ID:MB-4873,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:60.31,NPI:4.054,CELLULARITY:low,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:27,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:124.1333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-MED,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-4942,GRADE:3,COHORT:3,PATIENT_ID:MB-4942,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.75,NPI:4.044,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:216.9666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-4949,GRADE:3,COHORT:3,PATIENT_ID:MB-4949,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:75.2,NPI:5.044,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:220.0333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-4928,GRADE:3,COHORT:3,PATIENT_ID:MB-4928,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.92,NPI:3.036,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:186.4,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-5098,GRADE:null,COHORT:3,PATIENT_ID:MB-5098,TUMOR_STAGE:1
name:MB-5313
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:60.33,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:217.6333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4145,GRADE:null,COHORT:3,PATIENT_ID:MB-4145,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:77.66,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:125.7,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-5122,GRADE:null,COHORT:3,PATIENT_ID:MB-5122,TUMOR_STAGE:null
name:MB-5278
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:67.02,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:84.5,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4213,GRADE:2,COHORT:3,PATIENT_ID:MB-4213,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:73.2,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:174.8,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4126,GRADE:null,COHORT:3,PATIENT_ID:MB-4126,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:70.38,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:NA,OS_MONTHS:197.6666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4957,GRADE:2,COHORT:3,PATIENT_ID:MB-4957,TUMOR_STAGE:1
name:MB-5470
name:MB-5317
name:MB-5308
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:73.65,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:224.1,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4976,GRADE:1,COHORT:3,PATIENT_ID:MB-4976,TUMOR_STAGE:null
name:MB-5277
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:59.12,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-5110,GRADE:null,COHORT:3,PATIENT_ID:MB-5110,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:59.24,NPI:3.026,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:13,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:298.0333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4046,GRADE:2,COHORT:3,PATIENT_ID:MB-4046,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.23,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:277.3666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-MED,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4012,GRADE:null,COHORT:3,PATIENT_ID:MB-4012,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:58.32,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:147.8333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4141,GRADE:3,COHORT:3,PATIENT_ID:MB-4141,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:74.51,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:49.66666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4001,GRADE:2,COHORT:3,PATIENT_ID:MB-4001,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:49.92,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:40.63333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-4792,GRADE:3,COHORT:3,PATIENT_ID:MB-4792,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:42.27,CELLULARITY:low,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:176.0666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-4738,GRADE:2,COHORT:3,PATIENT_ID:MB-4738,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:72.17,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:163.2,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4264,GRADE:2,COHORT:3,PATIENT_ID:MB-4264,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:89.0,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:45.5,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4794,GRADE:null,COHORT:3,PATIENT_ID:MB-4794,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:43.85,NPI:5.0,CELLULARITY:null,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:null,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:NA,OS_MONTHS:251.0666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-4782,GRADE:2,COHORT:3,PATIENT_ID:MB-4782,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:65.76,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:60,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:223.3,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-5008,GRADE:3,COHORT:3,PATIENT_ID:MB-5008,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:70.84,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:45,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:170.9,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4426,GRADE:3,COHORT:3,PATIENT_ID:MB-4426,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:68.49,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:164.3333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4390,GRADE:2,COHORT:3,PATIENT_ID:MB-4390,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:74.84,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:148.1,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-4434,GRADE:3,COHORT:3,PATIENT_ID:MB-4434,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:74.6,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:119.4666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4368,GRADE:2,COHORT:3,PATIENT_ID:MB-4368,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:47.29,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:296.8666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-4442,GRADE:2,COHORT:3,PATIENT_ID:MB-4442,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:56.11,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:307.6333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4418,GRADE:2,COHORT:3,PATIENT_ID:MB-4418,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:59.75,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:61.46666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4381,GRADE:1,COHORT:3,PATIENT_ID:MB-4381,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:45.21,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:139.6,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:1,name:MB-4395,GRADE:3,COHORT:3,PATIENT_ID:MB-4395,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:67.48,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:95.83333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4630,GRADE:null,COHORT:3,PATIENT_ID:MB-4630,TUMOR_STAGE:null
name:MB-6010
name:MB-6021
name:MB-6059
name:MB-6154
name:MB-6097
name:MB-6107
name:MB-6023
name:MB-6152
name:MB-6018
name:MB-6082
name:MB-6029
name:MB-5295
name:MB-5386
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:76.37,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:174.5666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-5092,GRADE:3,COHORT:3,PATIENT_ID:MB-5092,TUMOR_STAGE:2
name:MB-6068
name:MB-6039
name:MB-6022
name:MB-6125
name:MB-6053
name:MB-6135
name:MB-6042
name:MB-6058
name:MB-6077
name:MB-6052
name:MB-5368
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:60.99,NPI:2.0,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:null,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:355.2,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:null,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-4189,GRADE:null,COHORT:3,PATIENT_ID:MB-4189,TUMOR_STAGE:null
name:MB-5335
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:64.91,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:44.73333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-4008,GRADE:3,COHORT:3,PATIENT_ID:MB-4008,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:46.58,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:196.5333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-5134,GRADE:2,COHORT:3,PATIENT_ID:MB-5134,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.05,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:165.4,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4139,GRADE:null,COHORT:3,PATIENT_ID:MB-4139,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:58.61,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:255.0,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:NA,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-5130,GRADE:3,COHORT:3,PATIENT_ID:MB-5130,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:38.59,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:37.36666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-5135,GRADE:3,COHORT:3,PATIENT_ID:MB-5135,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.68,NPI:4.054,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:27,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:NA,OS_MONTHS:210.9666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-4880,GRADE:3,COHORT:3,PATIENT_ID:MB-4880,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:52.57,NPI:4.002,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:1,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:187.7,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-5054,GRADE:3,COHORT:3,PATIENT_ID:MB-5054,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:39.25,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:56.33333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-5057,GRADE:3,COHORT:3,PATIENT_ID:MB-5057,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:68.55,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:176.3666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-MED,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4098,GRADE:null,COHORT:3,PATIENT_ID:MB-4098,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:48.41,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:124.8,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-4760,GRADE:null,COHORT:3,PATIENT_ID:MB-4760,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.93,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:30.36666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-5102,GRADE:3,COHORT:3,PATIENT_ID:MB-5102,TUMOR_STAGE:2
name:MB-5420
name:MB-5458
name:MB-5492
name:MB-5407
name:MB-5410
name:MB-5435
name:MB-5406
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:70.75,NPI:5.058,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:29,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:168.2666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4329,GRADE:3,COHORT:3,PATIENT_ID:MB-4329,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:66.37,NPI:3.036,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:188.3666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4005,GRADE:2,COHORT:3,PATIENT_ID:MB-4005,TUMOR_STAGE:1
name:MB-6288
name:MB-6272
name:MB-6218
name:MB-6246
name:MB-6217
name:MB-6308
name:MB-6271
name:MB-6245
name:MB-6233
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:68.09,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:NA,OS_MONTHS:198.6,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4343,GRADE:3,COHORT:3,PATIENT_ID:MB-4343,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:60.0,NPI:5.046,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:260.0333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-4281,GRADE:3,COHORT:3,PATIENT_ID:MB-4281,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:55.62,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:174.8333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4283,GRADE:2,COHORT:3,PATIENT_ID:MB-4283,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:35.14,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:33.7,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-4341,GRADE:3,COHORT:3,PATIENT_ID:MB-4341,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:66.91,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:89.03333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-4303,GRADE:3,COHORT:3,PATIENT_ID:MB-4303,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:74.32,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:59.93333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4274,GRADE:2,COHORT:3,PATIENT_ID:MB-4274,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:58.8,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:335.6,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4292,GRADE:3,COHORT:3,PATIENT_ID:MB-4292,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:68.32,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:244.2,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4278,GRADE:3,COHORT:3,PATIENT_ID:MB-4278,TUMOR_STAGE:2
name:MB-5399
name:MB-5364
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:60.3,NPI:5.044,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:86.06666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-3526,GRADE:3,COHORT:2,PATIENT_ID:MB-3526,TUMOR_STAGE:2
name:MB-6138
name:MB-6049
name:MB-6055
name:MB-6108
name:MB-6044
name:MB-6181
name:MB-6100
name:MB-6085
name:MB-6113
name:MB-6079
name:MB-6103
name:MB-6016
name:MB-6149
name:MB-6131
name:MB-6007
name:MB-6147
name:MB-6114
name:MB-6167
name:MB-6146
name:MB-6092
name:MB-6160
name:MB-6075
name:MB-6011
name:MB-6071
name:MB-6214
name:MB-6334
name:MB-6346
name:MB-6319
name:MB-6200
name:MB-6336
name:MB-6211
name:MB-6232
name:MB-6234
name:MB-6300
name:MB-5533
name:MB-5543
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:73.91,NPI:5.036,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:203.7,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-4236,GRADE:3,COHORT:3,PATIENT_ID:MB-4236,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:68.25,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:253.5333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4234,GRADE:3,COHORT:3,PATIENT_ID:MB-4234,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:37.85,NPI:5.036,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:neg,OS_MONTHS:98.7,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:9,name:MB-4270,GRADE:2,COHORT:3,PATIENT_ID:MB-4270,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:67.46,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:335.7333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-4235,GRADE:2,COHORT:3,PATIENT_ID:MB-4235,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:80.81,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:55,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:100.1666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4250,GRADE:2,COHORT:3,PATIENT_ID:MB-4250,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:80.04,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:126.6333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4323,GRADE:null,COHORT:3,PATIENT_ID:MB-4323,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:72.44,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:17.13333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-4318,GRADE:3,COHORT:3,PATIENT_ID:MB-4318,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:64.5,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:207.9666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4333,GRADE:1,COHORT:3,PATIENT_ID:MB-4333,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:74.98,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:173.6,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4339,GRADE:2,COHORT:3,PATIENT_ID:MB-4339,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:63.39,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:196.4666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4322,GRADE:2,COHORT:3,PATIENT_ID:MB-4322,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:70.27,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:68.13333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-4351,GRADE:3,COHORT:3,PATIENT_ID:MB-4351,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:41.54,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:215.1666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-5063,GRADE:3,COHORT:3,PATIENT_ID:MB-5063,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:59.16,NPI:4.016,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:8,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:11.86666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-4360,GRADE:3,COHORT:3,PATIENT_ID:MB-4360,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:40.04,NPI:3.032,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:291.1666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-4375,GRADE:2,COHORT:3,PATIENT_ID:MB-4375,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:44.51,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:257.1666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-4798,GRADE:2,COHORT:3,PATIENT_ID:MB-4798,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:38.1,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:45,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:neg,OS_MONTHS:244.4333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-4746,GRADE:3,COHORT:3,PATIENT_ID:MB-4746,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:74.39,NPI:3.198,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:99,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:200.7666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4838,GRADE:2,COHORT:3,PATIENT_ID:MB-4838,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:83.27,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:176.2666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4829,GRADE:null,COHORT:3,PATIENT_ID:MB-4829,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:71.67,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:NA,OS_MONTHS:43.9,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4802,GRADE:2,COHORT:3,PATIENT_ID:MB-4802,TUMOR_STAGE:2
name:MB-5426
name:MB-5444
name:MB-5431
name:MB-5447
name:MB-5434
name:MB-5231
name:MB-5339
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:52.43,NPI:4.054,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:27,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:151.9,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-5208,GRADE:3,COHORT:3,PATIENT_ID:MB-5208,TUMOR_STAGE:2
name:MB-5428
name:MB-5440
name:MB-5425
name:MB-5298
name:MB-5334
name:MB-5326
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:50.23,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:172.0,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4059,GRADE:2,COHORT:3,PATIENT_ID:MB-4059,TUMOR_STAGE:2
name:MB-6150
name:MB-6014
name:MB-6145
name:MB-6012
name:MB-6024
name:MB-6124
name:MB-6171
name:MB-6060
name:MB-6008
name:MB-6036
name:MB-6144
name:MB-5346
name:MB-5373
name:MB-6178
name:MB-6063
name:MB-6062
name:MB-6069
name:MB-6141
name:MB-6118
name:MB-6065
name:MB-6006
name:MB-6048
name:MB-6116
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:76.51,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:265.5666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4310,GRADE:1,COHORT:3,PATIENT_ID:MB-4310,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:70.58,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:189.0333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-4300,GRADE:3,COHORT:3,PATIENT_ID:MB-4300,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:68.16,NPI:4.064,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:32,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-4417,GRADE:3,COHORT:3,PATIENT_ID:MB-4417,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.17,NPI:4.044,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:351.0,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4079,GRADE:3,COHORT:3,PATIENT_ID:MB-4079,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:51.93,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:177.9,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-4317,GRADE:2,COHORT:3,PATIENT_ID:MB-4317,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:35.64,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:31.06666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-4350,GRADE:3,COHORT:3,PATIENT_ID:MB-4350,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:34.36,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:307.9333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-MED,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-4332,GRADE:3,COHORT:3,PATIENT_ID:MB-4332,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.22,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:87.23333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-4324,GRADE:3,COHORT:3,PATIENT_ID:MB-4324,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.19,NPI:2.042,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:234.7,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4306,GRADE:1,COHORT:3,PATIENT_ID:MB-4306,TUMOR_STAGE:2
name:MB-7226
name:MB-7205
name:MB-7160
name:MB-7159
name:MB-7167
name:MB-7207
name:MB-7237
name:MB-7241
name:MB-7236
name:MB-7168
name:MB-7162
name:MB-7235
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:63.34,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:235.5666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-4331,GRADE:3,COHORT:3,PATIENT_ID:MB-4331,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:59.23,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:128.5333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-4353,GRADE:3,COHORT:3,PATIENT_ID:MB-4353,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:55.01,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:15.36666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-4354,GRADE:2,COHORT:3,PATIENT_ID:MB-4354,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:64.12,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:199.2666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-4328,GRADE:2,COHORT:3,PATIENT_ID:MB-4328,TUMOR_STAGE:null
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:61.57,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:226.2,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-4348,GRADE:3,COHORT:3,PATIENT_ID:MB-4348,TUMOR_STAGE:2
name:MB-6030
name:MB-6133
name:MB-6083
name:MB-6026
name:MB-6168
name:MB-6101
name:MB-6156
name:MB-6051
name:MB-6182
name:MB-6080
name:MB-6143
name:MB-6164
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:76.32,NPI:3.064,CELLULARITY:null,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:32,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:51.96666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0551,GRADE:2,COHORT:1,PATIENT_ID:MB-0551,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:61.23,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:142.4666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-0391,GRADE:3,COHORT:1,PATIENT_ID:MB-0391,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:70.98,NPI:3.018,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:9,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:142.4333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0367,GRADE:2,COHORT:1,PATIENT_ID:MB-0367,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:46.79,NPI:3.022,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:11,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:185.0,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-5171,GRADE:2,COHORT:3,PATIENT_ID:MB-5171,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:65.35,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:204.4,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-5199,GRADE:3,COHORT:3,PATIENT_ID:MB-5199,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:68.53,NPI:5.0,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:null,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:65.23333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:null,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-5177,GRADE:3,COHORT:3,PATIENT_ID:MB-5177,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:65.26,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:184.3333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-5178,GRADE:3,COHORT:3,PATIENT_ID:MB-5178,TUMOR_STAGE:1
name:MB-5280
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:76.72,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:245.2333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-5148,GRADE:3,COHORT:3,PATIENT_ID:MB-5148,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:73.2,NPI:2.124,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:62,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:232.7666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-4342,GRADE:null,COHORT:3,PATIENT_ID:MB-4342,TUMOR_STAGE:3
name:MB-5225
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:56.14,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:124.1,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-4024,GRADE:3,COHORT:3,PATIENT_ID:MB-4024,TUMOR_STAGE:2
name:MB-6314
name:MB-6257
name:MB-6358
name:MB-6242
name:MB-6237
name:MB-6183
name:MB-6254
name:MB-6231
name:MB-6204
name:MB-6229
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:31.87,NPI:4.002,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:1,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:170.8333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-5154,GRADE:3,COHORT:3,PATIENT_ID:MB-5154,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:50.08,NPI:2.036,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:194.7,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-5175,GRADE:null,COHORT:3,PATIENT_ID:MB-5175,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.05,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:22.13333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-5173,GRADE:3,COHORT:3,PATIENT_ID:MB-5173,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:53.38,CELLULARITY:low,ONCOTREE_CODE:ILC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:NA,OS_MONTHS:164.3333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-5162,GRADE:2,COHORT:3,PATIENT_ID:MB-5162,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:48.76,NPI:4.026,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:13,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:80.5,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-5164,GRADE:3,COHORT:3,PATIENT_ID:MB-5164,TUMOR_STAGE:1
name:MB-7253
name:MB-7298
name:MB-7299
name:MB-7293
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:57.91,NPI:4.026,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:13,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:100.8666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-3978,GRADE:3,COHORT:2,PATIENT_ID:MB-3978,TUMOR_STAGE:1
name:MB-7288
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:37.01,NPI:6.074,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:37,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-2923,GRADE:3,COHORT:2,PATIENT_ID:MB-2923,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:73.06,NPI:2.022,CELLULARITY:low,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:11,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:99.73333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0402,GRADE:1,COHORT:1,PATIENT_ID:MB-0402,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:33.65,NPI:4.042,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:130.2,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-0381,GRADE:3,COHORT:1,PATIENT_ID:MB-0381,TUMOR_STAGE:2
name:MB-5271
name:MB-5235
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:58.39,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:30.36666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-4931,GRADE:3,COHORT:3,PATIENT_ID:MB-4931,TUMOR_STAGE:2
name:MB-5332
name:MB-7045
name:MB-7049
name:MB-7031
name:MB-7061
name:MB-7050
name:MB-7078
name:MB-7054
name:MB-7048
name:MB-7058
name:MB-7056
name:MB-7038
name:MB-7086
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:85.94,NPI:4.088,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:44,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:45.6,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-0177,GRADE:2,COHORT:1,PATIENT_ID:MB-0177,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:68.47,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:45,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:135.3333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-0399,GRADE:3,COHORT:1,PATIENT_ID:MB-0399,TUMOR_STAGE:3
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:46.63,NPI:5.056,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:28,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:97.56666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:1,name:MB-0388,GRADE:3,COHORT:1,PATIENT_ID:MB-0388,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:38.75,NPI:4.006,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:null,TUMOR_SIZE:3,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:34.76666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-0615,GRADE:2,COHORT:1,PATIENT_ID:MB-0615,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:46.44,NPI:4.042,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:189.1333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-0265,GRADE:2,COHORT:1,PATIENT_ID:MB-0265,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:42.55,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:60,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:122.2666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:6,name:MB-0116,GRADE:2,COHORT:1,PATIENT_ID:MB-0116,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:59.34,NPI:1.022,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:11,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:OTHER INVASIVE,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0472,GRADE:null,COHORT:1,PATIENT_ID:MB-0472,TUMOR_STAGE:0
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:81.02,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0191,GRADE:3,COHORT:1,PATIENT_ID:MB-0191,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:71.57,CELLULARITY:low,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:NA,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-MUC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0231,GRADE:null,COHORT:1,PATIENT_ID:MB-0231,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:69.88,NPI:4.056,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:28,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:97.83333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0558,GRADE:3,COHORT:1,PATIENT_ID:MB-0558,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:68.74,NPI:6.106,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:53,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:20.83333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-0393,GRADE:3,COHORT:1,PATIENT_ID:MB-0393,TUMOR_STAGE:3
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:86.99,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:85.73333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-0553,GRADE:2,COHORT:1,PATIENT_ID:MB-0553,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:50.41,NPI:4.048,CELLULARITY:low,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:24,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:91.26666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0587,GRADE:2,COHORT:1,PATIENT_ID:MB-0587,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:75.65,NPI:4.048,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:24,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:104.5333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0611,GRADE:3,COHORT:1,PATIENT_ID:MB-0611,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:66.09,NPI:3.026,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:13,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:61.33333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0640,GRADE:2,COHORT:1,PATIENT_ID:MB-0640,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:48.59,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-0114,GRADE:2,COHORT:1,PATIENT_ID:MB-0114,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:50.31,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:212.7,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0222,GRADE:null,COHORT:1,PATIENT_ID:MB-0222,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:51.42,NPI:1.0,CELLULARITY:moderate,ONCOTREE_CODE:BREAST,HORMONE_THERAPY:NO,LATERALITY:null,TUMOR_SIZE:0,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:NA,OS_MONTHS:0.0,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:BENIGN,BREAST_SURGERY:null,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0284,GRADE:null,COHORT:1,PATIENT_ID:MB-0284,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:85.09,NPI:5.068,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:34,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:35.6,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-0459,GRADE:3,COHORT:1,PATIENT_ID:MB-0459,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:57.4,NPI:3.028,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:14,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:137.8,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0128,GRADE:2,COHORT:1,PATIENT_ID:MB-0128,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:50.39,NPI:4.036,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:75.4,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0639,GRADE:3,COHORT:1,PATIENT_ID:MB-0639,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:58.01,NPI:1.036,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:168.7,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:OTHER INVASIVE,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-0318,GRADE:null,COHORT:1,PATIENT_ID:MB-0318,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:54.22,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:6.266666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0417,GRADE:2,COHORT:1,PATIENT_ID:MB-0417,TUMOR_STAGE:2
name:MB-6238
name:MB-6286
name:MB-6328
name:MB-6284
name:MB-6363
name:MB-6224
name:MB-6297
name:MB-6239
name:MB-6208
name:MB-6273
name:MB-6344
name:MB-6312
name:MB-6212
name:MB-6302
name:MB-6327
name:MB-6287
name:MB-6251
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:41.46,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:90.56666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER-,name:MB-0489,GRADE:3,COHORT:1,PATIENT_ID:MB-0489,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:54.96,NPI:3.058,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:29,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:125.3333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0342,GRADE:2,COHORT:1,PATIENT_ID:MB-0342,TUMOR_STAGE:null
name:MB-7289
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:56.81,NPI:5.052,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:55.83333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-3253,GRADE:3,COHORT:2,PATIENT_ID:MB-3253,TUMOR_STAGE:2
name:MB-7291
name:MB-7243
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:55.3,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:234.1333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-3466,GRADE:3,COHORT:2,PATIENT_ID:MB-3466,TUMOR_STAGE:1
name:MB-7286
name:MB-7292
name:MB-7275
name:MB-7249
name:MB-7295
name:MB-7297
name:MB-7294
name:MB-7296
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:41.17,NPI:5.056,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:28,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:neg,OS_MONTHS:50.03333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:1,name:MB-3402,GRADE:3,COHORT:2,PATIENT_ID:MB-3402,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:43.8,NPI:3.034,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:175.6333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:1,name:MB-5113,GRADE:2,COHORT:3,PATIENT_ID:MB-5113,TUMOR_STAGE:1
name:MB-5450
name:MB-7032
name:MB-7037
name:MB-7040
name:MB-7020
name:MB-7042
name:MB-7043
name:MB-7028
name:MB-7029
name:MB-7027
name:MB-7060
name:MB-7034
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:54.75,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:142.1666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-5191,GRADE:3,COHORT:3,PATIENT_ID:MB-5191,TUMOR_STAGE:1
HER2_SNP6:NEUT,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,AGE_AT_DIAGNOSIS:66.57,THREEGENE:ER+/HER2- Low Prolif,CELLULARITY:low,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,HORMONE_THERAPY:YES,LATERALITY:l,INTCLUST:2,name:MB-5214,COHORT:3,ER_IHC:pos,OS_MONTHS:107.3666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:76.91,NPI:2.048,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:24,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:191.9333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-5204,GRADE:null,COHORT:3,PATIENT_ID:MB-5204,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:51.08,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:259.9333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-5155,GRADE:null,COHORT:3,PATIENT_ID:MB-5155,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:53.07,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:242.5666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-5190,GRADE:3,COHORT:3,PATIENT_ID:MB-5190,TUMOR_STAGE:1
name:MB-5614
name:MB-5592
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:82.17,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:90.56666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0437,GRADE:2,COHORT:1,PATIENT_ID:MB-0437,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:86.41,NPI:5.032,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:36.56666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0028,GRADE:3,COHORT:1,PATIENT_ID:MB-0028,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:89.43,NPI:3.042,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:42.33333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0309,GRADE:1,COHORT:1,PATIENT_ID:MB-0309,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:68.68,NPI:4.078,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:39,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:8.066666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0100,GRADE:3,COHORT:1,PATIENT_ID:MB-0100,TUMOR_STAGE:2
name:MB-5572
name:MB-5655
name:MB-5577
name:MB-5620
name:MB-5652
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:59.8,NPI:3.028,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:14,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:113.5666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0537,GRADE:1,COHORT:1,PATIENT_ID:MB-0537,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:74.46,NPI:5.104,CELLULARITY:low,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:52,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:79.33333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0544,GRADE:3,COHORT:1,PATIENT_ID:MB-0544,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:60.95,NPI:6.052,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:129.4333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-0468,GRADE:3,COHORT:1,PATIENT_ID:MB-0468,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:53.56,NPI:3.052,CELLULARITY:low,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:144.4666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0205,GRADE:2,COHORT:1,PATIENT_ID:MB-0205,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:77.77,NPI:3.034,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:NA,OS_MONTHS:72.43333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-0233,GRADE:2,COHORT:1,PATIENT_ID:MB-0233,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.86,NPI:4.076,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:38,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:128.7,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0200,GRADE:3,COHORT:1,PATIENT_ID:MB-0200,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:67.83,NPI:2.022,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:11,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:149.7333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0244,GRADE:1,COHORT:1,PATIENT_ID:MB-0244,TUMOR_STAGE:1
name:MB-5588
name:MB-5628
name:MB-5633
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.19,NPI:3.024,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:12,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:152.3,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0253,GRADE:2,COHORT:1,PATIENT_ID:MB-0253,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:58.21,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:57.63333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0226,GRADE:1,COHORT:1,PATIENT_ID:MB-0226,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:34.3,NPI:5.106,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:null,TUMOR_SIZE:53,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:5.833333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:null,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-0278,GRADE:3,COHORT:1,PATIENT_ID:MB-0278,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:84.88,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:NA,OS_MONTHS:90.66666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0266,GRADE:null,COHORT:1,PATIENT_ID:MB-0266,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:51.42,CELLULARITY:low,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:10,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:65.4,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-MUC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0577,GRADE:2,COHORT:1,PATIENT_ID:MB-0577,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:60.12,NPI:4.032,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:neg,OS_MONTHS:163.8666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-0531,GRADE:3,COHORT:1,PATIENT_ID:MB-0531,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:54.76,NPI:1.028,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:14,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:164.7,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0245,GRADE:null,COHORT:1,PATIENT_ID:MB-0245,TUMOR_STAGE:1
name:MB-5641
name:MB-5640
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:51.56,NPI:5.034,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:124.1,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0534,GRADE:3,COHORT:1,PATIENT_ID:MB-0534,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:41.98,CELLULARITY:null,ONCOTREE_CODE:DCIS,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:NA,OS_MONTHS:200.3333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:DCIS,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-0230,GRADE:null,COHORT:1,PATIENT_ID:MB-0230,TUMOR_STAGE:0
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:82.53,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:null,TUMOR_SIZE:45,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:112.4,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:null,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0109,GRADE:3,COHORT:1,PATIENT_ID:MB-0109,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:84.85,NPI:5.028,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:14,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:111.5333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-0304,GRADE:3,COHORT:1,PATIENT_ID:MB-0304,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:65.47,NPI:6.054,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:27,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:144.3333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-0369,GRADE:3,COHORT:1,PATIENT_ID:MB-0369,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:54.1,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:0.766666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-0627,GRADE:3,COHORT:1,PATIENT_ID:MB-0627,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:85.21,NPI:4.056,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:28,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:81.13333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0492,GRADE:3,COHORT:1,PATIENT_ID:MB-0492,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:79.28,NPI:5.076,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:38,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:51.76666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-0147,GRADE:2,COHORT:1,PATIENT_ID:MB-0147,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:71.58,NPI:4.034,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:103.4666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0442,GRADE:2,COHORT:1,PATIENT_ID:MB-0442,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:54.23,NPI:2.054,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:27,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:127.1,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0111,GRADE:1,COHORT:1,PATIENT_ID:MB-0111,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:55.99,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:5,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:17.76666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0634,GRADE:2,COHORT:1,PATIENT_ID:MB-0634,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:47.64,NPI:3.042,CELLULARITY:null,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:172.9,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:7,name:MB-0280,GRADE:2,COHORT:1,PATIENT_ID:MB-0280,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:81.9,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:101.9666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0490,GRADE:2,COHORT:1,PATIENT_ID:MB-0490,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:74.63,NPI:4.042,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:104.4666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-0178,GRADE:3,COHORT:1,PATIENT_ID:MB-0178,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:51.25,NPI:3.036,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:NA,OS_MONTHS:199.1,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0242,GRADE:2,COHORT:1,PATIENT_ID:MB-0242,TUMOR_STAGE:1
name:MB-5624
name:MB-5593
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:73.15,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-4010,GRADE:3,COHORT:3,PATIENT_ID:MB-4010,TUMOR_STAGE:2
name:MB-5605
name:MB-5636
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.21,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:126.4666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-4529,GRADE:1,COHORT:3,PATIENT_ID:MB-4529,TUMOR_STAGE:1
name:MB-5566
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:66.54,NPI:4.038,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:null,TUMOR_SIZE:19,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:null,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0268,GRADE:3,COHORT:1,PATIENT_ID:MB-0268,TUMOR_STAGE:4
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.94,NPI:2.018,CELLULARITY:null,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:9,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:186.1,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-MUC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0275,GRADE:1,COHORT:1,PATIENT_ID:MB-0275,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:52.11,NPI:4.026,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:13,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:132.0666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0127,GRADE:2,COHORT:1,PATIENT_ID:MB-0127,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:45.27,NPI:5.038,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:19,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:neg,OS_MONTHS:164.9,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER-,name:MB-0045,GRADE:3,COHORT:1,PATIENT_ID:MB-0045,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:72.16,NPI:4.042,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:76.63333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0414,GRADE:3,COHORT:1,PATIENT_ID:MB-0414,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:38.99,NPI:6.0,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:null,TUMOR_SIZE:null,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:11.86666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:null,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:9,name:MB-0259,GRADE:3,COHORT:1,PATIENT_ID:MB-0259,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:56.45,NPI:4.054,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:27,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:60.66666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0396,GRADE:3,COHORT:1,PATIENT_ID:MB-0396,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:59.22,NPI:4.078,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:39,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0874,GRADE:3,COHORT:1,PATIENT_ID:MB-0874,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:56.39,NPI:6.068,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:34,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:17.93333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-0179,GRADE:3,COHORT:1,PATIENT_ID:MB-0179,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:72.18,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:null,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:neg,OS_MONTHS:139.6333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-0526,GRADE:3,COHORT:1,PATIENT_ID:MB-0526,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:77.99,CELLULARITY:low,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:65,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:77.23333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-0586,GRADE:2,COHORT:1,PATIENT_ID:MB-0586,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:42.68,NPI:3.022,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:11,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:114.3333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:2,name:MB-0508,GRADE:2,COHORT:1,PATIENT_ID:MB-0508,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:55.22,CELLULARITY:low,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:63.8,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-0288,GRADE:2,COHORT:1,PATIENT_ID:MB-0288,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:45.39,NPI:5.052,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:22.23333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER-,name:MB-0269,GRADE:3,COHORT:1,PATIENT_ID:MB-0269,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:84.76,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:15.53333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0582,GRADE:3,COHORT:1,PATIENT_ID:MB-0582,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:68.19,NPI:5.066,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:33,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:136.1666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0901,GRADE:3,COHORT:1,PATIENT_ID:MB-0901,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:75.65,NPI:6.044,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,OS_MONTHS:140.5,ER_IHC:pos,PR_STATUS:-,OS_STATUS:LIVING,CLAUDIN_SUBTYPE:claudin-low,BREAST_SURGERY:MASTECTOMY,HISTOLOGICAL_SUBTYPE:IDC,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0000,GRADE:3,COHORT:1,PATIENT_ID:MB-0000,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:46.66,NPI:3.024,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:12,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:199.1333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-0535,GRADE:2,COHORT:1,PATIENT_ID:MB-0535,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:67.94,NPI:5.078,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:39,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:131.2666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-0469,GRADE:3,COHORT:1,PATIENT_ID:MB-0469,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:74.02,NPI:4.046,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:23,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:132.3,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0478,GRADE:2,COHORT:1,PATIENT_ID:MB-0478,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:83.35,NPI:3.052,CELLULARITY:low,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:93.36666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:OTHER INVASIVE,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0170,GRADE:1,COHORT:1,PATIENT_ID:MB-0170,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:58.98,NPI:6.026,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:13,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:39.3,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0464,GRADE:3,COHORT:1,PATIENT_ID:MB-0464,TUMOR_STAGE:3
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:73.53,NPI:4.048,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:24,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:92.86666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-0421,GRADE:3,COHORT:1,PATIENT_ID:MB-0421,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:66.52,NPI:3.024,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:12,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:111.0666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0623,GRADE:2,COHORT:1,PATIENT_ID:MB-0623,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:55.09,NPI:4.058,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:29,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:73.13333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0241,GRADE:3,COHORT:1,PATIENT_ID:MB-0241,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:84.73,NPI:5.054,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:null,TUMOR_SIZE:27,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:98.1,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0163,GRADE:3,COHORT:1,PATIENT_ID:MB-0163,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:77.13,NPI:4.078,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:39,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:51.7,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0149,GRADE:3,COHORT:1,PATIENT_ID:MB-0149,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:49.05,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:null,TUMOR_SIZE:80,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:46.06666667,CLAUDIN_SUBTYPE:Basal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-MED,BREAST_SURGERY:null,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-0350,GRADE:3,COHORT:1,PATIENT_ID:MB-0350,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:56.74,NPI:2.048,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:24,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:121.5333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0512,GRADE:1,COHORT:1,PATIENT_ID:MB-0512,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:83.02,NPI:6.072,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:36,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:14.13333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-0046,GRADE:3,COHORT:1,PATIENT_ID:MB-0046,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:73.11,NPI:5.044,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:12.93333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0134,GRADE:3,COHORT:1,PATIENT_ID:MB-0134,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.19,NPI:6.038,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:19,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:71.8,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0495,GRADE:3,COHORT:1,PATIENT_ID:MB-0495,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:61.78,CELLULARITY:null,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:88.23333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0470,GRADE:1,COHORT:1,PATIENT_ID:MB-0470,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:82.34,NPI:4.028,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:14,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:152.0666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0872,GRADE:2,COHORT:1,PATIENT_ID:MB-0872,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:78.78,NPI:3.016,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:8,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:20.0,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0661,GRADE:2,COHORT:1,PATIENT_ID:MB-0661,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:90.43,NPI:3.048,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:24,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:NA,OS_MONTHS:26.73333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-MUC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0339,GRADE:2,COHORT:1,PATIENT_ID:MB-0339,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:83.93,NPI:5.062,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:31,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:NA,OS_MONTHS:43.1,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0264,GRADE:3,COHORT:1,PATIENT_ID:MB-0264,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:69.51,CELLULARITY:null,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:72.36666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-0175,GRADE:1,COHORT:1,PATIENT_ID:MB-0175,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:47.71,NPI:4.022,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:11,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:60.13333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:10,name:MB-0303,GRADE:3,COHORT:1,PATIENT_ID:MB-0303,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:48.11,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:138.1,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-0172,GRADE:2,COHORT:1,PATIENT_ID:MB-0172,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:73.98,NPI:2.018,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:9,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:1.266666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0125,GRADE:1,COHORT:1,PATIENT_ID:MB-0125,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:79.97,NPI:5.032,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:164.7333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:10,name:MB-0340,GRADE:3,COHORT:1,PATIENT_ID:MB-0340,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:56.27,NPI:3.052,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:94.23333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0234,GRADE:null,COHORT:1,PATIENT_ID:MB-0234,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:57.36,CELLULARITY:low,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:86.9,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0487,GRADE:2,COHORT:1,PATIENT_ID:MB-0487,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:60.62,CELLULARITY:low,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:63.5,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0305,GRADE:3,COHORT:1,PATIENT_ID:MB-0305,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:56.41,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:82.1,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0502,GRADE:3,COHORT:1,PATIENT_ID:MB-0502,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:57.76,NPI:4.032,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:55.36666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:null,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-0663,GRADE:3,COHORT:1,PATIENT_ID:MB-0663,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:56.75,NPI:2.034,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:153.5666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-0130,GRADE:1,COHORT:1,PATIENT_ID:MB-0130,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:75.91,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:71.6,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0289,GRADE:3,COHORT:1,PATIENT_ID:MB-0289,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:63.53,NPI:6.048,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:24,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:38.56666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-0129,GRADE:3,COHORT:1,PATIENT_ID:MB-0129,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:70.51,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:91.13333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-0343,GRADE:2,COHORT:1,PATIENT_ID:MB-0343,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:49.28,CELLULARITY:low,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:134.5,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-0458,GRADE:2,COHORT:1,PATIENT_ID:MB-0458,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:68.99,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:272.2,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-0570,GRADE:3,COHORT:1,PATIENT_ID:MB-0570,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:50.64,CELLULARITY:null,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:112.9333333,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-MUC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0488,GRADE:1,COHORT:1,PATIENT_ID:MB-0488,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:69.73,CELLULARITY:moderate,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:60,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:111.0666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:OTHER INVASIVE,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0655,GRADE:null,COHORT:1,PATIENT_ID:MB-0655,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:52.55,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:142.5666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0235,GRADE:2,COHORT:1,PATIENT_ID:MB-0235,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:38.72,NPI:5.044,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:82.63333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:6,name:MB-0484,GRADE:3,COHORT:1,PATIENT_ID:MB-0484,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:88.29,NPI:4.026,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:13,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:75.5,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-0436,GRADE:3,COHORT:1,PATIENT_ID:MB-0436,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:79.41,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:35,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:14.43333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:6,name:MB-0877,GRADE:3,COHORT:1,PATIENT_ID:MB-0877,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:78.19,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:98.7,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0097,GRADE:3,COHORT:1,PATIENT_ID:MB-0097,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:41.32,NPI:4.092,CELLULARITY:moderate,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:NO,LATERALITY:null,TUMOR_SIZE:46,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:NA,OS_MONTHS:30.96666667,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:null,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:4ER+,name:MB-0897,GRADE:2,COHORT:1,PATIENT_ID:MB-0897,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:80.5,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:55,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:49.76666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0095,GRADE:2,COHORT:1,PATIENT_ID:MB-0095,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:52.95,NPI:3.048,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:24,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:111.8666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0227,GRADE:2,COHORT:1,PATIENT_ID:MB-0227,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:86.26,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:41.83333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0353,GRADE:2,COHORT:1,PATIENT_ID:MB-0353,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:54.08,NPI:2.0,CELLULARITY:low,ONCOTREE_CODE:DCIS,HORMONE_THERAPY:NO,LATERALITY:null,TUMOR_SIZE:0,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:DCIS,BREAST_SURGERY:null,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-0522,GRADE:null,COHORT:1,PATIENT_ID:MB-0522,TUMOR_STAGE:0
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:67.06,NPI:5.066,CELLULARITY:high,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:33,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:15.16666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0646,GRADE:2,COHORT:1,PATIENT_ID:MB-0646,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:51.62,NPI:2.026,CELLULARITY:null,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:13,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:64.36666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-MUC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0293,GRADE:1,COHORT:1,PATIENT_ID:MB-0293,TUMOR_STAGE:1
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:61.53,NPI:6.058,CELLULARITY:null,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:29,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:68.06666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-0552,GRADE:3,COHORT:1,PATIENT_ID:MB-0552,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:78.26,NPI:1.024,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:12,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:169.8333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0260,GRADE:null,COHORT:1,PATIENT_ID:MB-0260,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:53.1,NPI:2.034,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:200.7,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0256,GRADE:1,COHORT:1,PATIENT_ID:MB-0256,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:61.11,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:20,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:35.53333333,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-0626,GRADE:3,COHORT:1,PATIENT_ID:MB-0626,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:42.95,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:44.8,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:9,name:MB-0211,GRADE:3,COHORT:1,PATIENT_ID:MB-0211,TUMOR_STAGE:null
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:43.46,CELLULARITY:low,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:50,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:118.2,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-0124,GRADE:2,COHORT:1,PATIENT_ID:MB-0124,TUMOR_STAGE:3
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:71.84,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:60,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:128.4,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0510,GRADE:3,COHORT:1,PATIENT_ID:MB-0510,TUMOR_STAGE:3
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:76.84,CELLULARITY:low,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:15,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:87.23333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-MUC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0365,GRADE:2,COHORT:1,PATIENT_ID:MB-0365,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:49.92,CELLULARITY:moderate,ONCOTREE_CODE:MDLC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:25,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:199.5333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC+ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:8,name:MB-0290,GRADE:1,COHORT:1,PATIENT_ID:MB-0290,TUMOR_STAGE:null
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:36.96,NPI:5.034,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:43.16666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-0113,GRADE:3,COHORT:1,PATIENT_ID:MB-0113,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:62.97,NPI:5.028,CELLULARITY:null,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:14,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:112.8,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:OTHER INVASIVE,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0620,GRADE:3,COHORT:1,PATIENT_ID:MB-0620,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:51.81,NPI:6.036,CELLULARITY:low,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:18,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:194.2333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-MUC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0282,GRADE:3,COHORT:1,PATIENT_ID:MB-0282,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:63.35,NPI:3.034,CELLULARITY:low,ONCOTREE_CODE:ILC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:10.83333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0228,GRADE:1,COHORT:1,PATIENT_ID:MB-0228,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:59.64,NPI:5.084,CELLULARITY:low,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:42,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:110.1,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0578,GRADE:2,COHORT:1,PATIENT_ID:MB-0578,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:33.83,NPI:4.044,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:132.7666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:5,name:MB-0479,GRADE:3,COHORT:1,PATIENT_ID:MB-0479,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:76.49,NPI:1.054,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:27,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:176.0333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0263,GRADE:null,COHORT:1,PATIENT_ID:MB-0263,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:41.48,NPI:4.022,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:11,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:115.3,CLAUDIN_SUBTYPE:Basal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-0509,GRADE:3,COHORT:1,PATIENT_ID:MB-0509,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:69.52,NPI:2.042,CELLULARITY:null,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:168.3333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0279,GRADE:1,COHORT:1,PATIENT_ID:MB-0279,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:60.26,NPI:4.034,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:17,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:122.7666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0168,GRADE:3,COHORT:1,PATIENT_ID:MB-0168,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:76.35,NPI:3.044,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:22,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:119.7333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-0588,GRADE:2,COHORT:1,PATIENT_ID:MB-0588,TUMOR_STAGE:2
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:60.5,NPI:4.032,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:132.7666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:HER2+,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-0462,GRADE:3,COHORT:1,PATIENT_ID:MB-0462,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:55.44,NPI:4.052,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:26,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:145.3,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:7,name:MB-0262,GRADE:3,COHORT:1,PATIENT_ID:MB-0262,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:82.35,NPI:2.032,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:111.1666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-0554,GRADE:null,COHORT:1,PATIENT_ID:MB-0554,TUMOR_STAGE:1
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:58.72,NPI:5.062,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:31,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:102.0666667,CLAUDIN_SUBTYPE:Her2,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:9,name:MB-0418,GRADE:3,COHORT:1,PATIENT_ID:MB-0418,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:51.54,NPI:6.038,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:19,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:19.0,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0193,GRADE:3,COHORT:1,PATIENT_ID:MB-0193,TUMOR_STAGE:null
HER2_STATUS:+,HER2_SNP6:GAIN,AGE_AT_DIAGNOSIS:85.12,NPI:5.042,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:21,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:96.23333333,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:5,name:MB-0652,GRADE:3,COHORT:1,PATIENT_ID:MB-0652,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:66.95,NPI:4.064,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:32,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:103.6333333,CLAUDIN_SUBTYPE:Normal,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0638,GRADE:2,COHORT:1,PATIENT_ID:MB-0638,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:82.65,CELLULARITY:high,ONCOTREE_CODE:ILC,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:45,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,CLAUDIN_SUBTYPE:Her2,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Disease,ER_STATUS:-,THREEGENE:null,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0188,GRADE:2,COHORT:1,PATIENT_ID:MB-0188,TUMOR_STAGE:2
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:72.14,CELLULARITY:low,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:YES,LATERALITY:r,TUMOR_SIZE:40,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:92.83333333,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC-MUC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER+,name:MB-0617,GRADE:1,COHORT:1,PATIENT_ID:MB-0617,TUMOR_STAGE:2
name:MB-7225
name:MB-7141
name:MB-7234
name:MB-7089
name:MB-7030
name:MB-7004
name:MB-7119
name:MB-7263
name:MB-7012
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:59.18,NPI:4.048,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:24,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:neg,OS_MONTHS:78.76666667,CLAUDIN_SUBTYPE:claudin-low,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:-,THREEGENE:ER-/HER2-,RADIO_THERAPY:YES,CHEMOTHERAPY:YES,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:4ER-,name:MB-0174,GRADE:3,COHORT:1,PATIENT_ID:MB-0174,TUMOR_STAGE:2
name:MB-7182
name:MB-7039
HER2_STATUS:-,HER2_SNP6:LOSS,AGE_AT_DIAGNOSIS:68.72,NPI:1.048,CELLULARITY:high,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:r,TUMOR_SIZE:24,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:228.3333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:null,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-3797,GRADE:null,COHORT:2,PATIENT_ID:MB-3797,TUMOR_STAGE:1
name:MB-7112
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:51.21,NPI:2.038,CELLULARITY:low,ONCOTREE_CODE:BRCA,HORMONE_THERAPY:NO,LATERALITY:null,TUMOR_SIZE:19,SAMPLE_TYPE:Primary,PR_STATUS:-,ER_IHC:pos,OS_MONTHS:183.2666667,CLAUDIN_SUBTYPE:LumA,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:IDC-TUB,BREAST_SURGERY:null,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:3,name:MB-0308,GRADE:1,COHORT:1,PATIENT_ID:MB-0308,TUMOR_STAGE:1
name:MB-7230
name:MB-5452
name:MB-6195
name:MB-6317
name:MB-5464
name:MB-5552
name:MB-5547
name:MB-6189
name:MB-6122
name:MB-6192
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:67.19,NPI:2.032,CELLULARITY:high,ONCOTREE_CODE:IDC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:16,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:57.3,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:null,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:2,name:MB-4820,GRADE:null,COHORT:3,PATIENT_ID:MB-4820,TUMOR_STAGE:null
name:MB-5527
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:60.46,CELLULARITY:moderate,ONCOTREE_CODE:ILC,HORMONE_THERAPY:YES,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:208.4,CLAUDIN_SUBTYPE:LumB,OS_STATUS:LIVING,HISTOLOGICAL_SUBTYPE:ILC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Living,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:NO,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:8,name:MB-5167,GRADE:null,COHORT:3,PATIENT_ID:MB-5167,TUMOR_STAGE:2
name:MB-5465
name:MB-5453
name:MB-5471
HER2_STATUS:-,HER2_SNP6:UNDEF,AGE_AT_DIAGNOSIS:74.98,CELLULARITY:low,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:30,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:191.4666667,CLAUDIN_SUBTYPE:LumB,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:MASTECTOMY,VITAL_STATUS:Died of Other Causes,ER_STATUS:+,THREEGENE:ER+/HER2- High Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:post,INTCLUST:1,name:MB-5127,GRADE:3,COHORT:3,PATIENT_ID:MB-5127,TUMOR_STAGE:2
name:MB-4313

name:MTS-T0058
name:MTS-T0071
name:MTS-T0072
name:MTS-T0073
name:MTS-T0074
name:MTS-T0075
name:MTS-T0076
name:MTS-T0077
name:MTS-T0078
name:MTS-T2129
name:MTS-T2117
name:MTS-T2055
name:MTS-T2096
name:MTS-T2047
name:MTS-T2107
name:MTS-T2074
name:MTS-T2068
name:MTS-T2053
name:MTS-T1922
name:MTS-T1945
name:MTS-T1329
name:MTS-T2116
name:MTS-T1659
name:MB-4313
name:MTS-T1633
name:MTS-T1576
name:MTS-T2126
name:MTS-T1872
name:MTS-T1517
name:MTS-T1515
name:MTS-T1503
name:MTS-T0558
name:MTS-T2404
name:MTS-T2398
name:MTS-T0737
name:MTS-T2412
name:MTS-T2392
name:MTS-T2402
name:MTS-T2415
name:MTS-T2391
name:MTS-T2406
name:MTS-T0528
name:MTS-T0525
name:MTS-T2090
name:MTS-T0516
name:MTS-T0510
name:MTS-T0515
name:MTS-T0508
name:MTS-T0479
name:MTS-T0490
name:MTS-T0466
name:MTS-T0468
name:MTS-T0456
name:MTS-T2405
name:MTS-T1522
name:MTS-T1954
name:MTS-T1865
name:MB-6206
name:MTS-T1991
name:MTS-T2018
name:MTS-T2030
name:MTS-T1971
name:MTS-T1983
name:MTS-T1548
name:MTS-T2128
HER2_STATUS:-,HER2_SNP6:NEUT,AGE_AT_DIAGNOSIS:45.44,NPI:2.022,CELLULARITY:moderate,ONCOTREE_CODE:IDC,HORMONE_THERAPY:NO,LATERALITY:l,TUMOR_SIZE:11,SAMPLE_TYPE:Primary,PR_STATUS:+,ER_IHC:pos,OS_MONTHS:141.7333333,CLAUDIN_SUBTYPE:LumA,OS_STATUS:DECEASED,HISTOLOGICAL_SUBTYPE:IDC,BREAST_SURGERY:BREAST CONSERVING,VITAL_STATUS:Died of Disease,ER_STATUS:+,THREEGENE:ER+/HER2- Low Prolif,RADIO_THERAPY:YES,CHEMOTHERAPY:NO,INFERRED_MENOPAUSAL_STATE:pre,INTCLUST:3,name:MB-4832,GRADE:1,COHORT:3,PATIENT_ID:MB-4832,TUMOR_STAGE:1
name:MTS-T1527
name:MTS-T1583
name:MTS-T1561
name:MTS-T1549
name:MTS-T1516
name:MTS-T1582
name:MTS-T1502
name:MTS-T1537
name:MTS-T1605
name:MTS-T1526
name:MTS-T1571
name:MTS-T1504
name:MTS-T1326
name:MTS-T1525
name:MTS-T1560
name:MTS-T1454
name:MTS-T1616
name:MTS-T1514
name:MTS-T1501
name:MTS-T0824
name:MTS-T0877
name:MTS-T1366
name:MTS-T0883
name:MTS-T2407
name:MTS-T2409
name:MTS-T2393
name:MTS-T2413
name:MTS-T2416
name:MTS-T2414
name:MTS-T2410
name:MTS-T2403
name:MTS-T2408
name:MTS-T0788
name:MTS-T0079
name:MTS-T0080
name:MTS-T0081
name:MTS-T0082
name:MTS-T0083
name:MTS-T0084
name:MTS-T0085
name:MTS-T0063
name:MTS-T0059
name:MTS-T0060
name:MTS-T0061
name:MTS-T0062
name:MTS-T0064
name:MTS-T0065
name:MTS-T0066
name:MTS-T0067
name:MTS-T0068
name:MTS-T0069
name:MTS-T0070